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ABSTRACT 
 
Sarah A. Kennedy 
Structural and Molecular Dynamics Simulation Studies Support Symplekin’s Protein 
Scaffolding Role and A Novel Fold in the TraI Relaxase-Helicase C-Terminus is 
Essential for Conjugative DNA Transfer 
(Under the direction of Professor Matthew R. Redinbo) 
 
The majority of eukaryotic pre-mRNAs are processed by 3’-end cleavage and 
polyadenylation, although in metazoa the replication-dependant histone mRNAs are 
subject only to 3’-end cleavage and not polyadenylation.  The macromolecular complex 
responsible for processing both canonical and histone pre-mRNAs contains the ~1,160-
residue protein Symplekin. Secondary structural prediction algorithms identified putative 
HEAT domains in the 300 N-terminal residues of all Symplekins of known sequence.   
The structure and dynamics of this domain was investigated to begin to elucidate the role 
Symplekin plays in mRNA maturation.  The crystal structure the D. melanogaster 
Symplekin HEAT domain was determined to 2.4 Å resolution using SAD phasing 
methods. The structure exhibits five canonical HEAT repeats along with an extended 29 
amino acid loop between the fourth and fifth repeat (loop 8) that is both unique and 
conserved in Symplekin sequences.  Molecular dynamics simulations of this domain 
show that loop 8 dampens the overall motion of the HEAT domain, therefore providing a 
stable surface for potential protein-protein interactions.  HEAT domains are often 
employed for such macromolecular contacts, and the Symplekin HEAT region 
structurally aligns with several established scaffolding proteins.  Taken together, these 
iv 
 
data support the conclusion that the Symplekin HEAT domain serves as a scaffold for 
protein-protein interactions essential to the mRNA maturation process.  
The TraI relaxase-helicase is the central catalytic component of the multi-protein 
relaxosome complex responsible for conjugative DNA transfer (CDT) between bacterial 
cells.  CDT is a primary mechanism for the lateral propagation of microbial genetic 
material, including the spread of antibiotic resistance genes.  The 2.4 Å resolution crystal 
structure of the C-terminal domain of the multifunctional E. coli F plasmid TraI protein 
(TraI-CT) is presented, and specific structural regions essential for CDT are identified.  
The crystal structure reveals a novel fold composed of a 39-residue N-terminal α-helical 
extension connected by a proline-rich loop to a compact α/β core domain.  Both the 
globular nature of the α/β-domain and the presence and rigidity of the proline-rich loop 
are required for DNA transfer and single-stranded DNA binding.   Taken together, these 
data establish the specific structural features of this non-catalytic domain that are 
essential to DNA conjugation.  
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PREFACE 
 
 After graduating with a B.S. in Chemistry from Westminster College and working 
as a Research Technician at Solvay Advanced Polymers, I realized that I wanted to have 
a higher impact role in the chemical industry, so I knew I had to further my education.  I 
truly enjoyed learning about biochemistry and I wanted to transition from synthetic 
polymer chemistry to studying human polymers: DNA, RNA and proteins.  Wondering 
about the atomic level interactions among these polymers, I decided to pursue structural 
biology, specifically X-ray crystallography, so that I could understand how to solve and 
evaluate the three dimensional structures of biological molecules. 
 Matthew Redinbo, a highly regarded scientist in the field of X-ray 
crystallography, interviewed me for graduate school and we communicated well from the 
very beginning of my summer rotation.  Upon joining his laboratory, he pitched 
numerous different options for projects, and I worked on several before deciding that I 
would like to bring something brand new into his laboratory.  I spent about a month 
reading current literature and spoke to several groups on campus about potential 
crystallography projects.  Finally, we set up collaborations with Dr. William Marzluff 
and Dr. Bob Duronio of the UNC Biology Department to study proteins involved in 
messenger RNA processing.  The work characterizing Symplekin, a protein central to 
mRNA processing, is addressed in the first five chapters of this manuscript.   
 Besides working on Symplekin, I spent the past year studying TraI, a protein that 
has been a central focus in the Redinbo Laboratory.  The sixth chapter is focused on 
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solving the structure of the previously uncharacterized TraI C-terminal domain and 
determining its role in conjugative DNA transfer.  The final chapter details preliminary 
work to characterize the central GTPase domain of TraI, including structural predictions 
through sequence analysis and preliminary assay development.  A summary of my short-
term work on the expression and purification of human spermatozoa protein, Eppin, is 
also discussed in the final chapter. 
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Chapter 1. Introduction to Symplekin 
 
1.1 Introduction 
 In this scientific age, multidisciplinary approaches and collaborations between 
scientific groups have become imperative for understanding the complexities involved in 
even the simplest of biochemical processes.  As a scientist, I understand the importance of a 
multi-faceted approach to answering tough questions.  In the following five chapters, I 
describe the work I have done to understand a single protein, Symplekin, and how its 
structure relates to its biological function in messenger RNA processing and cellular tight 
junctions.  My structure and dyanimics results will be complemented by two collaborating 
laboratories, who are also working to understand Symplekin’s biochemical and genetic role 
in the model system D. melanogaster.  Deirdre Tatomer, under the direction of geneticist Dr. 
Bob Duronio, is exploring the phenotype of a Symplekin-null fly, and also designing 
experiments to visualize different cellular junctions for the presence of Symplekin.  Dr. 
Mindy Steiniger, under the direction of biochemist/cell biologist Dr. William Marzluff, is 
working to understand Symplekin’s role in binding transcription factors and also in histone 
messenger RNA processing.  This introductory chapter will survey the current literature to 
detail Symplekin’s role in 3’-end mRNA processing and at cellular tight junctions.  Control 
of Symplekin by sumoylation and phosphorylation will be discussed, followed by a 
discussion of Symplekin’s interactions with several transcription factors.   
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1.2 Canonical messenger RNA 3’-end processing 
 The central dogma of molecular biology describes the flow of genetic information 
from DNA to RNA to protein; DNA is transcribed to RNA, which is translated into protein.  
In order for RNA to be translated to protein, several processes must occur to prepare the 
messenger RNA.  These processes include adding both a 5’-end 7-methylguanosine cap and a 
3’-end polyadenylic acid (poly(A)) tail, and splicing of non-protein coding introns.  The 5’ 
cap and the introns splicing are not studied herein.  The poly(A) tail on the mRNA has 
multiple purposes, each of which is important to proper cellular function1,2.  If the 3’-end of 
the mRNA is not properly formed, developmental problems can occur due to the instability 
of the message or improper levels mRNA translation1.  Several cases of ocular dystrophy, 
thalassemias and lysosomal storage disorder have been linked to aberrant 3’-end 
polyadenylation1.  Specifically, depletion of CstF-64, an essential 3’-end processing factor,  
disrupts proper 3’-end formation and leads to cell cycle arrest and apoptosis3.  The addition 
of a 30-nt poly(A) tail stabilizes the mRNA transcript and protects the message from 
unregulated degradation, since deadenylation is one of the principle ways that mRNA 
degradation is triggered4-6.  Also, the poly(A) tail promotes the export of the mRNA from the 
nucleus to the cytoplasm for translation initiation7,8 and transcription termination is promoted 
by the synthesis of the poly(A) tail9.   Studying the proteins, RNA elements and mechanism 
of 3’-end cleavage and polyadenylation will lead to a better understanding of the intricate 
regulatory nature of transcription termination and translation initiation. 
 The addition of the poly(A) tail requires two steps.  First, an endonucleolytic cleavage 
occurs at a conserved CA sequence in the 3’ untranslated region (UTR).  Then, the 3’-end is 
subject to adenylic acid polymerization.  While this seems like a fairly simple two step 
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process, many RNA recognition sites and proteins are necessary for proper 3’-end 
processing.  Many recent reviews have discussed the cleavage and polyadenylation proteins 
and RNA recognition sequences in plant, yeast, and mammalian systems1,2,5,10.  Figure 1.1, 
taken from Dominski et al., shows the main machinery involved in canonical mRNA 
processing in mammals11.  The following section discusses the main RNA and protein 
elements responsible for the 3’ cleavage and polyadenylation reactions. 
 The mammalian RNA recognition sites include a U-rich sequence, followed by an 
AAUAAA sequence that is approximately 30 nucleotides upstream of the CA cleavage site 
and then a GU-rich element follows 30 nucleotides downstream of the cleavage site1,12.  The 
AAUAAA sequence is necessary for both polyadenylation and cleavage; mutations in this 
region strongly inhibit processing1,13,14.  While the GU-rich downstream element (DSE)  
sequence can be variable, position is important, and the DSE must be located within 30 
nucleotides of the cleavage site15.  Yeast and plants have both the U-rich and AAUAAA 
sequences; however, they are slightly less conserved than in mammals.  The CA cleavage site 
is also slightly different: the A is conserved, but the C can be either C or U in these two 
species.  
 In mammals, four multi-protein complexes (CstF, CFIm, CFIIm, and CPSF), poly(A) 
polymerase (PAP), poly(A) binding protein (PABP), RNA Polymerase II C-terminal domain 
(PolII CTD), and Symplekin are all required for 3’-end processing12.  The mammalian CPSF 
(Cleavage and Polyadenylation Specificity Factor) complex includes subunits CPSF-73, 
CPSF-100, CPSF-30, CPSF-160 and hFip1, each of which binds to RNA.  CPSF-73 is the 
main cleavage enzyme responsible for cleaving the CA RNA sequence in the 3’ UTR16.  The 
CstF complex is composed of CstF-50, -64, and -77.  CstF-50 and CstF-77 bind to PolII 
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CTD, CstF-64 binds to the DSE in the mRNA, and CstF-77 links the CstF to the CPSF 
complex.  CFIm is regulated by phosphorylation and provides additional recognition of the 
pre-mRNA substrate, which helps to define the correct polyadenylation site and binding of 
PAP17,18.  CFIIm has two subunits, Pcf11 and Clp1: in yeast Pcf11 binds to PolII CTD, CstF 
and Symplekin, while Clp1 has an ATP-binding domain and binds to CPSF and CFIm.   
 The remaining factors include PAP, PABP, PolII CTD and Symplekin.  Poly(A) 
polymerase (PAP) is the main protein required to add AMP molecules to the pre-mRNA19,20.  
Poly(A)-binding protein (PABP) binds to stretches of 11-14 poly(A) nucleotides and 
regulates the proper tail length21,22.  The CTD of PolII is necessary for 3’-cleavage in 
mammals but not yeast, and it has been shown that in vitro 3’-end processing reactions are 
stimulated by phosphorylated CTD23-25.  Symplekin forms a complex with CPSF and CstF 
and in has been shown to be required for both cleavage and polyadenylation in yeast12,26,27.  
Symplekin is proposed to be a scaffold that is essential for forming the properly oriented 3’ 
processing machinery.  
 As described, this seemingly simple two step reaction of cleavage and 
polyadenylation requires multiple factors and intertwined protein-protein and protein-RNA 
interactions.  Separating functions of each protein has been very challenging because of the 
interdependent nature of the interactions.  In fact, the most recent experiments on the human 
pre-mRNA 3’ processing complex indicate that this purified complex contains over 85 
proteins, 50 of which are important to correlate 3’-end processing with other cellular 
processes28.  Further information about these interactions is outlined in several 
reviews1,12,20,29.   As a structural biologist, I am interested in understanding the structural 
basis for the formation of the main components of the 3’-end processing machinery.  At this 
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point, the structures of many of the proteins have been determined, including portions of 
CPSF 73, CPSF 100, CPSF 30, CstF 64, CstF 77, PAP-Fip1, and CF Im-25.  Thus, I focused 
on understanding an essential protein in this process that had no structural information 
available to date: Symplekin.  
 
1.3 Symplekin’s role in canonical mRNA 3’-end processing 
 Yeast Symplekin (named Pta1) is required for both cleavage and polyadenylation of 
canonical mRNA27.  In the yeast polyadenylation system, Pta1 has been shown to be present 
in a complex with the human homologues of CPSF-73, CPSF-100, and five other factors that 
have no known mammalian counterparts: Ssu72p, Swd2p, Syc1p, Pti1p, Glc7p30-33.  
Symplekin has been shown to bind with both CstF-64 and CstF-77, but in a mutually 
exclusive manner 26.  Thus, Symplekin is proposed to be a scaffold upon which the CstF 
complex is assembled in the correct orientation.  Unpublished work from the Marzluff 
laboratory (UNC-CH) shows that Symplekin binds to CPSF-73 and CPSF-100.  Symplekin is 
colocalized with CPSF-100 in Cajal bodies during oocytes maturation and binds directly to 
CPSF and CPEB to regulate protein-protein interactions in cytoplasmic polyadenylation34,35. 
Taken together, these data suggest Symplekin is a protein essential for mRNA processing by 
providing a scaffold on which protein-protein interactions can occur.     
 
1.4 Symplekin’s role in histone mRNA 3’-end processing 
 Histone mRNAs, are different than canonical mRNA in that they only require a 3’-
end cleavage and not 3’-end polyadenylation.  Histone mRNA 3’-end structure is that of a 
stem-loop sequence.  Figure 1.2 illustrates the difference between the 3’-end structure of 
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canonical and histone mRNAs.  The factors involved in histone mRNA processing are 
slightly different than those required for canonical mRNA.  Figure 1.3, taken from Dominski 
et al., shows the macromolecular machinery involved in histone mRNA 3’-end processing11.  
Common factors to both canonical and histone mRNA processing include Symplekin, CPSF-
73 and CPSF-100.  Unpublished data by Sullivan, Steiniger and Marzluff indicate that CPSF-
73, Symplekin and CPSF-100 form a core complex that is required for histone pre-mRNA 
processing in D. melanogaster.   
 Symplekin was initially discovered to play a part in histone processing by Kolev and 
Steitz, who identified Symplekin as the main component of the heat labile factor (HLF), 
which was responsible for the disruption of histone mRNA 3’-end processing in heat-treated 
HeLa nuclear extracts36.  Adding Symplekin restored histone mRNA processing and 
demonstrated the reassembly of the multi-subunit complex containing CPSF and CstF36.  
Once again, data points towards Symplekin playing a role as a scaffold for the integrity of the 
3’-end processing machinery.   
 
1.5 Sumoylation and phosphorylation regulate Symplekin 
  Vethantham et al. discovered that sumoylation modulates the activities of both 
CPSF73 (the endonucleolytic cleavage factor for 3’-end mRNA processing) and 
Symplekin37.   Highly conserved sumoylation sites in Symplekin and CPSF-73 are targeted 
by SUMO-2/3 and desumoylation of Symplekin or CPSF-73 by adding a SUMO protease 
reduces 3’-end processing and inhibits the proper assembly of the 3’-end processing 
complex37.  In addition to sumoylation, phosphorylation also exerts a level of regulation in 
mRNA processing.  In the yeast polyadenylation complex, He et al. demonstrated that 
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reduction of phosphatase Glc7p levels lead to a decrease in the length of poly(A) tails and 
also to the accumulation of phosphorylated Pta133.  Addition of unphosphorylated Pta1 
rescued the 3’-end processing reactions.  These two results show that Symplekin is controlled 
by two common regulatory molecules and indicates that Symplekin has a regulatory role for 
3’-end processing in addition to scaffolding CPSF and CstF in the correct orientation for 
cleavage and polyadenylation. 
 
 1.6 Symplekin is also found at epithelial cell tight junctions 
 Before Symplekin’s role in mRNA processing was documented, this protein was 
shown to be involved in cellular tight junctions of several epithelial cell lines.  Tight 
junctions, also known as zonula occludens, composed mainly of the transmembrane protein 
occludin, form a gasket-like link between epithelial or endothelial cells to provide a fence-
like hydrophobic barrier between lumina38,39.   A program to provoke antibody production for 
tight junctional plaque proteins produced a monoclonal antibody specific to Symplekin.  
Using immunofluorescence, cell fractionation, RNA isolation, DNA sequencing and protein 
characterization methods, Keon et al. revealed a 1142 residue human protein present at tight 
junctions40.  They named the protein Symplekin, which in Greek means “to tie together, to be 
intertwined, to weave”.  In all of the cell types analyzed, Symplekin was found in the 
nucleoplasm, but only in cell lines forming tight junctions was Symplekin found to be 
present in the plaque of zonula occludens40,41.  Keon’s study revealed that Symplekin was 
very specifically found in the zonula occludens, rather than zonula adherins40.  Thus, 
Symplekin was able to be used as a differential marker for identification of cells forming 
zonula occludens, which has been proposed to be useful in assessing tight junctional 
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formation in certain carcinomas39,40.  Another study shows the presence of Symplekin in the 
outer limiting zone of the retina, a new type of adhering junction42.  The exact purpose for 
Symplekin at these tight junctions is not known.  Presently, no studies have linked 
Symplekin’s role in tight junctions to its role in mRNA processing.  However, it is possible 
that Symplekin plays a scaffolding role at tight junctions, just as it is predicted to scaffold 
factors for mRNA processing. 
  
1.7 Symplekin modulates transcription factors ZONAB and HSF1 
Symplekin also serves as bridging factor between the 3’-end machinery and 
transcription regulators.  Specific examples of Symplekin’s role in transcription regulation by 
interaction with transcription factors HSF1 and ZONAB have been shown43,44. HSF1 binds to 
the HSP gene promoters to upregulate expression of heat shock proteins in response to 
cellular stress. The N-terminal 125 residues of Symplekin interact with heat shock factor 1 
(HSF1) in the nuclei of heat stressed cells44.  Disruption of the HSF1-Symplekin interaction 
reduced the polyadenylation of mRNA encoding HSP70 thus limiting the ability of the cell to 
respond to stress44.  CstF64 was also found co-localized with the HSF1-Symplekin complex. 
Thus, Symplekin’s role in helping to upregulate HSP70 expression during heat stress has 
been established and demonstrates Symplekin’s role in coupling mRNA polyadenylation to 
protein expression.   
ZONAB is found in the nucleus, where it participates in transcription regulation, and 
is also found at epithelial cell tight junctions bound to ZO-1. Kavanagh et al. demonstrate 
through confocal microscopy and epifluorescence that Symplekin and ZONAB are 
colocalized in the nucleus of MDCK (canine epithelial cells) and this nuclear interaction can 
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be immunoprecipitated and also reconstituted with recombinant proteins43.  Through a 
luciferase reporter assay, Symplekin was observed to modulate ZONAB’s transcriptional 
activity43.  Undoubtedly, future studies will probe more deeply into the mechanism that 
Symplekin uses for regulating transcription factors and show more links between 
transcription regulation and mRNA processing.  Symplekin’s role in 3’-end messenger RNA 
processing has clear implications for it’s regulation of available mature RNA molecules that 
can be translated to protein.  Symplekin interacts with transcription factors like HSF1 and 
ZONAB and may bridge the 3’-end processing machinery to the transcription regulation 
machinery.  
 
1.8 Understanding Symplekin through crystallography and molecular dynamics 
 Table 1.1 summarizes the published Symplekin protein-protein interactions.  The 
table includes species, specific residues if known, and method of detection.  Most of these 
interactions have not been studied in sufficient detail to pinpoint the exact regions of binding 
within each protein. However, three independent studies, in yeast or human cells, have 
shown the N-terminus of Symplekin binds to transcription factor HSF1 and phosphatases 
Ssu72 and Glc7p33,44,45.  Thus, this section of Symplekin appears to be a protein scaffold 
important for regulation of mRNA processing by phosphorylation and transcription factor 
modulation.  I used a combination of crystallography and molecular dynamics simulations to 
investigate the N-terminal region of Symplekin.  The following chapters discuss the 
identified domains within Symplekin, the structure determination of the N-terminal HEAT 
domain and the role that a conserved unique loop plays in the dynamics of this domain.  
Throughout these experiments, it becomes increasingly clear that Symplekin’s HEAT 
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domain does in fact form a structural scaffold with the ability to accommodate multiple 
diverse binding partners.   
 
 
1.9 Figures and Tables  
Figures and tables are listed in the same order as they appear in the text of chapter 1. 
Figure 1.1 Canonical mRNA 3’-end processing machinery bound to an mRNA molecule 
 
Figure 1.2 Cartoon representations illustrating the difference in 3’-end processing of 
canonical and histone mRNAs 
 
Figure 1.3 Histone mRNA 3’-end processing machinery bound to histone mRNA  
Table 1.1 Symplekin’s known interactions and methods of detection 
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5’
3’
 
 
Figure 1.1 Canonical mRNA 3’-end processing machinery bound to an mRNA molecule 
 
Figure legend from Dominski et al.11 The processing machinery involved in cleavage/ 
polyadenylation. The arrow indicates the site of cleavage by CPSF-73. The position of some 
of the components in the complex has not been experimentally supported. The model does 
not include the CTD that is required for in vitro cleavage/polyadenylation under certain 
experimental conditions11. 
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Primary mRNA transcript
UTR         Protein-coding       UTR    Poly-A tail                      5’ 3’
Mature mRNA transcript
3’- Cleavage and 
Polyadenylation
CAUTR                  Protein-coding              UTR                                    5’ 3’
A
 
 
3’-Cleavage
5’ 3’
5’ 3’
Mature Histone mRNA
Primary Histone mRNA
UTR  Protein-coding                 UTR                                       
UTR   Protein-coding
B
 
Figure 1.2 Cartoon representations illustrating the difference in 3’-end processing of 
canonical and histone mRNAs 
 
Illustration of 3’-end processing reactions for (A) canonical mRNA and (B) histone mRNAs.  
UTR stands for untranslated region.  
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5’ 3’
 
 
Figure 1.3 Histone mRNA 3’-end processing machinery bound to histone mRNA11  
Figure legend from Dominski et al.  Known components of the 3′ end processing 
machinery cleaving histone pre-mRNAs. The position of Symplekin in the complex is 
hypothetical and the presence of CPSF-100 has not been supported experimentally11. 
 
SLBP (stem-loop binding protein) and ZPF100 recognize the mRNA stem loop.  CPSF73 is 
the main endonucleolytic enzyme and is thought to dimerize with CPSF 100.  Proteins B, D3, 
G, E, F, Lsm11 and Lsm10 are Sm core proteins, which are part of the U7 snRNP 
responsible for recognizing the 3’ histone downstream element that is distant from the CA 
cleavage site. 
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Table 1.1 Symplekin’s known interactions and methods of detection 
O
th
er
 p
ro
te
in
in
 v
iv
o
in
 v
itr
o
D
et
ec
tio
n 
m
et
ho
d(
s)
Sp
ec
ie
s/c
el
l l
in
e
O
th
er
 d
et
ai
ls
C
ita
tio
n
oc
cl
ud
in
x
im
m
un
of
lu
or
es
ce
nc
e 
co
lo
ca
liz
at
io
n
hi
H
T-
29
co
lo
ca
liz
ed
 a
t t
ig
ht
 ju
nc
tio
n
K
av
an
ag
h
x
im
m
un
of
lu
or
es
ce
nc
e 
co
lo
ca
liz
at
io
n
ca
ni
ne
, M
D
C
K
co
lo
ca
liz
ed
 a
t n
uc
le
us
 a
nd
 ti
gh
t j
un
ct
io
n
K
av
an
ag
h
x
co
im
m
un
op
re
ci
pi
ta
tio
n 
hi
C
ac
o-
2,
 M
D
C
K
ZO
-1
 p
re
ci
pi
ta
te
s a
ls
o
K
av
an
ag
h
x
pu
ll-
do
w
n 
w
ith
 re
co
m
bi
na
nt
 p
ro
te
in
-
-
K
av
an
ag
h
x
lu
ci
fe
ra
se
 re
po
rte
r t
ra
ns
cr
ip
tio
n 
as
sa
y
M
D
C
K
, h
iH
T-
29
ad
di
tiv
e 
tra
ns
cr
ip
tio
n 
re
pr
es
si
on
K
av
an
ag
h
ZO
-1
x
co
im
m
un
op
re
ci
pi
ta
tio
n
hi
H
T-
29
-
K
av
an
ag
h
x
x
Y
ea
st
 tw
o 
hy
br
id
 a
nd
 p
ul
l d
ow
n 
as
sa
ys
m
ou
se
 
m
Sy
m
pl
ek
in
 1
-1
24
 in
te
ra
ct
s w
ith
 H
SF
1
X
in
g
x
im
m
un
op
re
ci
pi
ta
tio
n
hu
m
an
nu
cl
ea
r e
xt
ra
ct
s o
f h
ea
t s
ho
ck
ed
 H
eL
a 
ce
lls
X
in
g
x
im
m
un
of
lu
or
es
ce
nc
e 
co
lo
ca
liz
at
io
n
hu
m
an
nu
cl
ea
r e
xt
ra
ct
s o
f h
ea
t s
ho
ck
ed
 H
eL
a 
ce
lls
X
in
g
x
im
m
un
op
re
ci
pi
ta
tio
n,
 in
di
re
ct
 th
ru
 H
SF
1
hu
m
an
nu
cl
ea
r e
xt
ra
ct
s o
f h
ea
t s
ho
ck
ed
 H
eL
a 
ce
lls
X
in
g
x
co
im
m
un
op
re
ci
pi
ta
tio
n
hu
m
an
H
eL
a 
ce
ll 
nu
cl
ea
r e
xt
ra
ct
s, 
C
st
F-
64
 1
00
-2
00
Ta
ka
ga
ki
x
co
im
m
un
op
re
ci
pi
ta
tio
n
hu
m
an
in
 v
itr
o 
tra
nl
sa
te
d 
pr
ot
ei
ns
Ta
ka
ga
ki
C
st
F-
77
x
co
im
m
un
op
re
ci
pi
ta
tio
n
hu
m
an
in
 v
itr
o 
tra
nl
sa
te
d 
pr
ot
ei
ns
Ta
ka
ga
ki
Ss
u7
2
x
x
im
m
un
op
re
ci
pi
ta
tio
n,
 p
ul
l d
ow
n 
as
sa
y
ye
as
t
-
H
e
Su
b1
x
x
im
m
un
op
re
ci
pi
ta
tio
n,
 p
ul
l d
ow
n 
as
sa
y
ye
as
t
-
H
e
Sw
d2
p
s
pu
ll 
do
w
n 
as
sa
y
ye
as
t
D
ic
ht
l
C
ft2
p/
Y
dh
1p
x
pu
ll 
do
w
n 
as
sa
y
ye
as
t
C
ft2
p/
Y
dh
1p
 is
 a
 h
um
an
 C
PS
F-
10
0 
ho
m
ol
og
ue
K
yb
ur
z
x
co
im
m
un
op
re
ci
pi
ta
tio
n
ye
as
t
in
te
ra
ct
io
n 
ob
se
rv
ed
 in
 p
ur
ifi
ed
 C
FI
I
Zh
ao
x
x
Y
ea
st
 tw
o 
hy
br
id
 a
nd
 p
ul
l d
ow
n 
as
sa
ys
ye
as
t
br
r5
 is
 a
 h
um
an
 C
PS
F-
73
 h
om
ol
og
ue
Zh
el
ko
vs
ky
Sy
c1
p
x
pu
ll 
do
w
n 
as
sa
y
ye
as
t
Zh
el
ko
vs
ky
G
lc
7
x
pu
ll 
do
w
n 
as
sa
y
ye
as
t
G
lc
7 
ph
os
hp
at
as
e 
bi
nd
s 1
01
-2
01
 o
f p
ta
1
H
e
C
PE
B
x
co
im
m
un
op
re
ci
pi
ta
tio
n
xe
no
pu
s o
oc
yt
es
-
B
ar
na
rd
C
PS
F-
10
0
x
co
im
m
un
op
re
ci
pi
ta
tio
n
xe
no
pu
s o
oc
yt
es
-
B
ar
na
rd
ZO
N
A
B
/D
bp
A
H
SF
1
C
st
F-
64
br
r5
15 
 
 
 
 
 
Chapter 2. Cloning, expressing and crystallizing the HEAT 
domain of Drosophila melanogaster Symplekin 
 
2.1 Introduction 
 As described in chapter one, Symplekin is involved in transcriptional regulation and 
mRNA 3’-end processing, it is present at tight junctions and is regulated by sumoylation and 
phosphorylation.  The diverse functionality and the lack of structural information made 
Symplekin a fascinating target for biophysical and structural characterization.  As mentioned 
previously, collaborators at UNC-CH are also working on Symplekin, specifically in the D. 
melanogaster model system.  I chose to work with this species of Symplekin, so that our 
work would directly correlate.  This chapter focuses on the work leading up to solving the 
crystal structure of the Symplekin HEAT domain.  First, discovery of well-folded structural 
motifs by primary sequence analysis is discussed.  Then, cloning and test expression 
procedures for various Symplekin constructs are outlined.  Finally, the purification, 
crystallization, and structure determination of the N-terminal Symplekin HEAT domain is 
described.   
 
2.2 Structural prediction of Symplekin domains 
 Generally, the first step in designing a crystallization target is to examine the primary 
amino acid sequence for predicted secondary structure and domains.  In general, large 
regions that are predicted to be disordered can disrupt crystal packing and are also more 
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prone to proteolysis during protein purification.  The following software programs were 
utilized to find symplekin orthologs and predict the structural elements within Symplekin: 
BLAST46, Jpred47, PHYRE48, pFam49, InterProScan50, ScanSite51, PredictProtein52, RONN53 
and COILS54.  BLAST identifies homologous proteins to that of your search sequence, 
whereas pFam, InterProScan, PredictProtein and ScanSite search your sequence against 
classes of characterized functional domains.  Jpred and PHYRE assign secondary structural 
elements to your primary sequence.  PHYRE also creates models of your protein based on 
similar published structures and scores them with E-values.  RONN specifically finds areas 
of predicted disorder and COILS predicts regions of coiled-coils within the primary 
sequence.    
 Domain predictions for full length Symplekin were made by combining the 
predictions from each of these sites (Figure 2.1).  The disordered regions include 1-18, 452-
544, and 1116-1165.  A HEAT domain was predicted between residues 19-271, a region with 
predicted alpha helical structure follows immediately after the HEAT domain at residues 
272-451, and the C-terminal portion between 545-1116 is predicted to fold into an armadillo 
domain.   No additional domains were predicted for Symplekin, thus a catalytic activity is 
most likely not going to be attributed to Symplekin.  Rather a scaffolding role for protein or 
nucleic acid interactions is its predicted function based on its structural elements. 
 
2.3 Construct design, cloning and test expressions 
 The original full length cDNA encoding D. melanogaster Symplekin in the pGEX 
vector was obtained from Dr. Mindy Steiniger in Dr. Bill Marzluff’s laboratory at UNC-CH.  
I cloned the putative domains into the pMCGS9 vector with either 6xHis or 6xHis-MBP tags 
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utilizing ligation independent cloning55.  Table 2.1 lists all of the constructs that I cloned and 
test expressed in E. coli.  Figure 2.2 shows a representative test expression for Symplekin 
634-1082 and 669-1082 in the pMCGS9 plasmid (from Sondek lab at UNC-CH).  In this 
case, two different amounts of IPTG were added to induce protein expression under the lac 
operon.  Unfortunately, this protein was present in the insoluble fraction.  No attempt at 
expressing the C-terminal armadillo domain in bacterial cells resulted in soluble protein 
expression.  Full length Symplekin protein did express in bacterial cells, however, upon 
purification, there was always a cleavage event, which cut the protein roughly in half.  
Despite attempts to stabilize the full length protein with the use of protease inhibitors, Triton 
X-100, salt concentrations varied from 0-500 mM and a pH range of 7-8, the full length 
protein never was able to resist truncation.  Thus, crystallization quality full length protein 
was not obtained.  The result of all of the test expressions was the soluble overproduction of 
Symplekin 19-271 in the LIC-MBP vector in BL21 cells.  Since HEAT domains are common 
in scaffolding proteins, three regulatory proteins bind to this region of Symplekin,  and no 
structural information had yet been published on Symplekin or its homologues, I began to 
focus on crystallizing this HEAT domain to understand its’ potential scaffold role. 
 
2.4 Expression and purification of the Symplekin HEAT domain 
 As mentioned above, residues 19-271 of D. melanogaster Symplekin were cloned 
into the expression vector pMCGS9 (also known as the LIC plasmid), which provided N-
terminal 6-histidine and maltose-binding protein (MBP) tags followed by a Tobacco Etch 
Virus (TEV) protease site56.  E. coli BL21 (DE3) gold cells (Stratagene) were transformed 
with the plasmid and cells were grown at 37 °C in 1.5 L of terrific broth supplemented with 
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50 mg/L ampicillin until an A600=1.0-1.2 at which time the temperature was dropped to 18 °C 
and 0.1 mM of IPTG was added to induce protein expression overnight until a final OD 
A600=4.5.  The cells were harvested by 20 min 1600 g centrifugation and resuspended in 20 
mL of nickel buffer A (5 mM imidazole, 50 mM potassium phosphate, pH 7.4, 150 mM 
NaCl, 1 mM dithiothreitol, 0.01% sodium azide) and stored at -80°C.   The cells were lysed 
by sonication in the presence of DNase and a protease inhibitor cocktail and then centrifuged 
at 40,000 g for 60 minutes to produce a cleared lysate.  The protein was purified away from 
the lysate by nickel affinity chromatography (Figure 2.3A).  Nickel buffer B (500 mM 
imidazole, 50 mM potassium phosphate, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.01% sodium 
azide) was used to elute the protein with a gradient of 5-100% B.  To cleave the 6xHis-MBP-
Symplekin fusion, 2% TEV protease by mass TEV/mass Symplekin was added (Figure 
2.3B).  Protein was dialyzed into nickel buffer A during TEV cleavage.  A second nickel 
column or amylose column purified the now un-tagged Symplekin from the 6×His-MBP tag 
(Figure 2.3C).  A polishing step of size exclusion chromatography (Column: Superdex 75, 
GE Healthcare; sizing buffer: 10 mM HEPES, pH 8.0, 50 mM NaCl, 1 mM DTT and 0.01% 
sodium azide) cleaned the protein to greater than 95% purity, by SDS-PAGE (Figure 2.3D).   
A selenomethionine-derivative of residues 19-271 of D. melanogaster Symplekin was 
grown using E. coli B834 cells, a methionine auxotroph cell line.  Cells were grown in 
selenomethionine specific media (Athena) supplemented with 50 mg/L selenomethionine.  
The culture was grown at 37 °C until an OD of 0.6, then the temperature was reduced to 
18°C and 0.l mM IPTG was added to induce overexpression of the derivative protein 
overnight.  Purification procedures were identical to those listed above for the native protein. 
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2.5 Crystallization of Symplekin HEAT domain 
 Typically protein crystallization begins with commercially available matrix screens 
that explore multiple pH values, salt conditions and precipitant concentrations.  However, 
since the structure of Symplekin was proposed to be a HEAT domain, a literature search of 
similar structures was performed to develop a reasonable set of crystallization conditions.  
Ann Mast, an undergraduate working with my on this project, helped to put together this 
information and design screens around the published conditions used to crystallize other 
HEAT domains.  
 Native and selenomethionine derivative Symplekin proteins were concentrated to 3-6 
mg/mL in the sizing buffer.  Crystallization was performed by hanging drop diffusion at 
22°C with mother liquor consisting of 0.4-0.5 M sodium citrate, 25-28% PEG 3350, 10 mM 
HEPES, pH 8.0, 0.01% N3Na and 1 mM DTT.  Each crystallization drop contained 1 µL of 
protein and 1 µL of well solution.  Diamond shaped crystals grew within one week; the 
largest ones had the dimensions 300 µm x 60 µm x 60 µm.  Figure 2.4 shows representative 
Symplekin 19-271 crystals.  Multiple cyro-protectant solutions similar to the mother liquor 
were screened by cooling them in liquid nitrogen and visualizing their transparency.  Finally, 
crystals were cryoprotected in mother liquor plus 35% PEG 3350 or perfluoroether oil and 
flash-cooled in liquid nitrogen.  
 A fluorescence scan was performed on the selenomethionine-derived Symplekin 
crystal to confirm the presence of a strong selenium signal (Figure 2.5).  Diffraction data 
were collected at 100K using Sector 22-BM (SER-CAT) of the Advanced Photon Source at 
Argonne National Laboratories.  A strategy of 1° oscillation with two second exposure and 
collection of 360° of data was most ideal for completeness and redundancy.  Figure 2.6 
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illustrates a diffraction image from the native data collection.  A SAD data set was collected 
on the seleno-methionine-derivative Symplekin crystals at selenium edge of 0.97190 Å; a 
native data set was collected at 0.97958 Å.  DENZO and SCALEPACK in HKL-2000 were 
used to index and scale the data57.  The crystals were in the space group P41212 with unit cell 
dimensions of a, b = 68.7 Å , c = 138.5 Å and α, β, γ = 90°.  More detailed data collection 
statistics are listed in Table 2.2.  
 
2.6 Data processing and structure refinement 
The SGXPRO software package58, an interface for programs including SHELXD59 
and SOLVE/RESOLVE60, was used to solve the heavy atom sites and initial phases.  A 
Matthews coefficient value of 2.9 indicated with 99% probability that 1 molecule was 
expected in the asymmetric unit with 57.6% solvent.  Six methionine residues were present in 
Symplekin 19-271, thus six Se sites were expected.  SHELXD and SOLVE identified all six 
Se atom positions, and the initial phase was calculated to 2.9 Å.  RESOLVE was used for 
density modification and to provide an initial model. After these steps, the overall figure of 
merit was 0.69. Figure 2.7 illustrates the original experimental electron density with the final 
model of the Symplekin protein, thus validating the phase solution found using SGXPRO58. 
 The model was built by hand using COOT61.  Initially, all helices were built with 
alanine residues.  Loops were added over several rounds of refinement to connect the helices.  
Finally, side chains were placed in the model.  This 2.9 Å model from the SAD data was 
refined using REFMAC5 at this stage to R and Rfree values of 0.353 and 0.419, respectively.  
To phase the 2.4 Å native data set, the selenium-derivative model was used in molecular 
replacement62.  Further refinement was conducted by building and validating the model in 
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coot, and employing both CNS and REFMAC5.  Final statistics (Table 2.3) include R and 
Rfree values of 0.2068 and 0.2653, respectively.  For both the original SAD data and the final 
native data, 5% of the data were set aside for the free-R and not used at any stage of 
refinement.  The final model, consisting of 248 residues (no density was present for residues 
19-21 and 271) and 142 water molecules, was validated with PROCHECK and Molprobity63. 
Figure 2.8 illustrates a portion of the final model in the electron density from the 2.9 Å data 
set (A) and the 2.4 Å data set (B).  The improvement in resolution can be clearly seen in this 
example of electron density.   
 
2.7 Figures and Tables 
Figures and tables are listed in the same order as they appear in the text of chapter 2. 
Figure 2.1 Predicted domains within D. melanogaster Symplekin. 
Table 2.1 List of Symplekin constructs and test expression conditions 
Figure 2.2 Test expression of Symplekin 634-1082 and 669-1082 
Figure 2.3 Purification of Symplekin 19-271 
Figure 2.4 Crystals of Symplekin 19-271 
Figure 2.5 Fluorescence scan for selenium anomalous scattering 
Figure 2.6 An X-ray diffraction image from a native Symplekin crystal 
Table 2.2 Data collection statistics for X-ray diffraction of Symplekin 19-271 
Figure 2.7 Wall-eyed stereo view of original experimental density with final model 
Table 2.3 Data processing and refinement statistics for Symplekin 19-271 
Figure 2.8 Density modified and refined electron density maps of a portion of the Symplekin 
structure 
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Figure 2.1 Predicted domains within D. melanogaster Symplekin. 
The numbers above the figure represent amino acid positions.  Red circles denote areas with 
predicted disorder.  HEAT repeats are predicted between 19-271 followed by an α-helical 
region between 272-451.  An armadillo domain is predicted for the C-terminal half of the 
protein.  The N and C termini are labeled.   
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Table 2.1 List of Symplekin constructs and test expression conditions 
Construct Tags E. coli Cell Line Temperatures (°C) IPTG (mM)
1-1165 His, MBP, GST BL21, BL21-RIPL, BL21-RIL, BL21-Origami 37, 18 0.1, 1
1-477 His, MBP BL21, BL21-RIPL, BL21-RIL, BL21-Origami 18 0.1, 1
19-271 His, MBP BL21, BL21-RIPL, BL21-RIL, BL21-Origami 37, 18 0.1, 0.5, 1
528-1165 His, MBP BL21, BL21-RIPL, BL21-RIL, BL21-Origami 18 0.1, 1
634-1082 HIS BL21 18 0.1, 1 
669-1082 HIS BL21 18 0.1, 1  
His is a 6xhistidine tag , MBP is maltose binding protein, GST is glutathione-S-transferase.  
All tags are on the N-terminus of the Symplekin construct.   
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Figure 2.2 Test expression of Symplekin 634-1082 and 669-1082 
SDS-page gel of the E. coli BL21 test expression of Symplekin constructs 634-1082 and 669-
1082 in the pMCGS9 plasmid.  The IPTG row represents the mM of IPTG used to induce 
protein expression (Unind corresponds to a sample taken before induction).  The fraction row 
designates L for molecular weight ladder, Sol for soluble fraction and Ins for insoluble 
fraction.  The theoretical molecular weight for 634-1082 is 52.3 kD, while 669-1082 is 48.2 
kD.   This is a representative gel from all of the test expressions.   Samples were prepared by 
lysing a cell pellet from 1 mL of induced bacterial cells, then separating soluble and insoluble 
fractions with centrifucation at 17,000 rpm for 30 minutes.  These proteins were not subject 
to any purification steps. 
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Figure 2.3 Purification of Symplekin 19-271 
SDS-page gels of the purification scheme for Symplekin 19-271.  L represents the molecular 
weight markers, FT stands for flow through, Clvg stands for a sample showing the cleavage 
by TEV protease.  (A)  Representative fractions from a nickel column with cleared lysate.  
The MBP-Symplekin protein runs at 70 kD.  (B) Gel showing the result of the overnight 
TEV cleavage reaction to cleave the 42 kD MBP tag from the 28 kD Symplekin construct. 
(C) Amylose column run after the TEV cleavage reaction.  Untagged Symplekin (28 kD) 
now flows off of the column, while MBP (42 kD) binds to the amylose resin.  (A gel run on a 
nickel column sample at this stage has the same elution profile).  (D) Final purification step 
of size exclusion chromatography yields > 95% pure untagged Symplekin 19-271.    
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100 microns  
Figure 2.4 Crystals of Symplekin 19-271 
This is an illustration of Symplekin crystals grown in 425 mM sodium citrate, 26% PEG 
3350, 10 mM HEPES-KOH, pH 8.0, 1 mM DTT.  Crystals were grown by hanging drop 
diffusion at 22°C after 5 days. 
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Figure 2.5 Fluorescence scan for selenium anomalous scattering 
This X-ray energy scan of a selenomethionine-derivative crystal demonstrates the presence 
of a strong anomalous scattering signal at the selenium absorption edge.  The most 
anomalous scattering is seen at 12.66 keV, which was the wavelength used for the SAD data 
collection. 
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Figure 2.6 An X-ray diffraction image from a native Symplekin crystal 
The X-ray diffraction pattern from this native crystal represents clear, well resolved, intense 
reflections that were used in data processing.   Data was collected at the Advanced Photon 
Source, Argonne National Labs at the SER-CAT BM-22 beamline with a MarCCD detector.   
The reflections furthest from the center represent 2.2 Å resolution.
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Table 2.2 Data collection statistics for X-ray diffraction of Symplekin 19-271 
X-ray source APS SER-CAT BM-22
Space Group P41212
Unit cell a,b,c (Å); α, β, γ (°) 68.7, 68.7, 138.5; 90, 90, 90
Data set SeMet Native
Wavelength (Å) 0.97190 0.97958
Resolution (Å)                          
(highest shell)
50.0-2.9       
(3.0-2.9)
50.0-2.4      
(2.49-2.40)
Rsym 9.4 (34.4) 8.0 (41.9)
I/σ 22.4 (1.0) 24.8 (1.9)
Completeness (%) 78.1 (6.7) 96.1 (79.6)
Redundancy 10.4 (1.6) 6.4 (2.8)
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Figure 2.7 Wall-eyed stereo view of original experimental density with final model 
Experimental density calculated from structure factors and phases by single-wavelength 
anomalous dispersion data covering the final model of Symplekin.  The density is contoured 
to 1σ.   
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Table 2.3 Data processing and refinement statistics for Symplekin 19-271 
Resolution (Å) 50.0-2.4
No. reflections 12465
Rwork 0.2068
Rfree 0.2653
Molecules per asymetric unit (AU) 1
No. of amino acids per AU 248
No. of waters per AU 142
Average B-factors 46.37
R.M.S.D. Bond lengths (Å) 0.0059
R.M.S.D. Bond angles (°) 1.20
Ramachandran (%) favored 96.76
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Figure 2.8 Density modified and refined electron density maps of a portion of the 
Symplekin structure 
 
Simple electron density map contoured to 1σ around the final model of Symplekin residues 
leucine 100 through methionine 110.  Letters corresponds to amino acid residues and 
numbers are consistent with the numbering of D. melanogaster Symplekin.  Valine 108 and 
leucine 101 are boxed to show the dramatic effect of improved resolution. (A) Electron 
density map from 2.9 Å resolution selenomethionine derivative. (B) Electron density map 
from 2.4 Å resolution native data. 
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Chapter 3. Structural characterization of the  
Symplekin HEAT domain 
 
3.1 Overall structural fold and interesting features 
Residues 19-271 consists of a single domain with 5 bi-helical HEAT repeats forming 
an overall cradle-like shape with curvature of ~140° on the concave surface.  This domain is 
named after four proteins that contain HEAT repeats: Huntingtin, Elongation factor 4, the 
PR65/A subunit of protein phosphatase 2A and the lipid kinase TOR.  The 10 HEAT helices 
(residues 22-256) are lettered conventionally for HEAT repeat domains; helices composing 
the convex surface are labeled A, and concave surface helices are designated B (Figure 3.1). 
Each repeat is labeled in sequential number order with the short sixth helix labeled α6.  
Repeats 1-5 contain 37, 37, 47, 46, and 42 residues, respectively, falling into the range of 
residues established for HEAT repeats.  Residues 257-270 form a short helix, perhaps 
leading into an additional unpredicted HEAT repeat, of which the first portion is observed in 
the crystal structure.  The convex (A) helices are tilted slightly relative to the concave (B) 
helices.  The interior of the protein forms a hydrophobic core, while the concave and convex 
surfaces are composed of mainly charged residues.   
             Symplekin residues 187-217 form an extended loop (loop 8) that caps the ends of 
α4B and α5B.  A series of molecular salt bridges hold loop 8 in position (Figure 3.2).  
Bridges within the loop include the 2.8 Å bond between the backbone nitrogen of D192 and 
side-chain oxygen of S195, and the 2.9 Å bond between S203 backbone nitrogen and D206 
side-chain oxygen.  Residues involved in the six salt bridges between the loop and the HEAT 
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domain include helical bound residues M257 and R258 of α5B, K132 of α3B, and residues 
S195, G200, D201, and S203 of loop 8.  All of these electrostatic interactions with loop 8 are 
shown in Figure 3.2.  R258, D192, D201 and S203, which are involved in the salt bridges, 
are conserved among Symplekin homologues in the four higher eukaryotes and thus may 
play an important functional role.  Comparisons of this loop with other HEAT domains 
indicate that it is a unique feature (see below). 
 
3.2 Classification of individual HEAT repeats 
HEAT domains are commonly found in solenoid structures that are protein scaffolds 
for multiprotein complexes64-73.  Based on the specific amino acid positions in the structure, 
the HEAT repeats can be subclassified further into structural/functional families64.   To sub-
classify each HEAT repeat, the individual repeats were structurally aligned to HEAT repeat 
2, by DaliLite74(Figure 3.3A).  Repeats 1, 2, 4 and 5 aligned well; however, repeat 3 is 
elongated and bent respective to the others, which is interesting because the unique loop 8 
packs against this elongated helix as seen in Figure 3.1.  Each of the repeats were compared 
to the sequence logo of three classes of HEAT sequences (ADB, AAA and IMB) reviewed in 
Andrade et al.64.  All three classes, AAA, ADB, and IMB, contain conserved residues D19, 
V/I 24 and R/K 25.  The AAA and IMB classes have a highly conserved P11 a hydrophobic 
residue at position 9. The ADB class lack P11, has a conserved hydrophobic residue at 28, 
and D/N/E at position 21.  HEATs 1 and 5 are difficult to characterize because they are 
terminal repeats and have a different set of packing constraints64.  HEAT repeat 2 contains 
the conserved residues common to all three classes: D77, V82 and R83.  However, it lacks 
P11 and has N21 (N79), which indicates HEAT 2 belongs to the ADB class.  HEAT repeat 3 
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includes D114, N115, I120, and K121, while HEAT repeat 4 contains 167D, 170N, 173I and 
R174, both lack prolines at position 11.  Thus, all central repeats belongs to the ADB family. 
Figure 3.3B illustrates the conserved D19 and R25 present in both Symplekin HEAT repeats 
2 and 4.  This small ADB subclass contains α, β-adaptin and β-coat proteins that function as 
scaffolds for protein binding and transport.  This sub-classification supports the hypothesis 
that the Symplekin HEAT domain has a structure appropriate for protein-protein interactions.   
 
3.3 Amino acid conservation on the concave surface 
 Figure 3.4 shows the alignment of the N-terminus of Symplekin conserved residues 
among a wide range of species: Homo sapiens, Xenopus laevis, D. melanogaster, 
Strongylocentrotus purpuratus, Caenorhabditis elegans, Saccharomyces cerevisiae, and 
Arabidopsis thaliana (At1g27590).  Previous published alignments only demonstrated the 
similarity in the center of the molecule26, so this alignment demonstrates that the N-terminus 
of the Symplekin family is also conserved. Due to the diversity of these species, only five 
positions are 100% identical, but over the 247 positions in the HEAT domain, 96 are highly 
similar (defined as ≥6 species with similar residues).  Within these 96 residues, 73 are 
nonpolar and are present to maintain the structural hydrophobic core of the HEAT domain.  
In general, the greater the species divergence the less the less the specific amino acid is 
conserved.   Thus, when comparing the sequences of more closely related eukaryotes (H. 
sapiens, X. laevis, D. melanogaster, and M. musculus) (Figure 3.5), many more positions in 
the primary sequence are conserved.  
Mapping conservation onto the three dimensional structure indicates regions that are 
the most likely to be important for function.  The hydrophobic core of Symplekin is highly 
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conserved with 28 identical residues (Figure 3.6).  By comparing the level of conservation in 
the concave, convex and loop regions of Symplekin, it is evident that the majority of 
identical residues fall on the concave surface and within loops (Figure 3.7A).  The concave 
surface is lined with conservation, accounting for more than 20% of the total conserved 
residues in this HEAT domain.  The convex surface contains only 4 conserved residues: R27, 
V31, M110, and E149. (Figure 3.7B).  Examination of loop 8 in these four species shows 
that five residues are 100% conserved and seven positions contain highly similar residues 
(Figure 3.5 and Figure 3.7A, cyan).  Since residue conservation often implies functional 
importance, both the concave face and loop 8 are most likely important for Symplekin’s 
biological function.  
  
3.4 Symplekin HEAT domain structurally aligns with several other HEAT domains 
Now that the conservation of the amino acids points to the functional importance of 
the concave surface and loop 8, other HEAT domains with closely related structures to 
Symplekin were investigated to understand how this domain typically interacts with binding 
partners. Other members of the HEAT domain family include serine/threonine-protein 
phosphatase 2A, Cullin-associated protein Cand1, and karyopherin α-1 subunit.  
Experimental evidence available for these proteins shows that their HEAT repeats are 
involved in protein-protein interactions and the majority of known HEAT repeat structures 
utilize their concave face as a binding or scaffolding surface66,69,71,75-78. To better understand 
the Symplekin HEAT domain and how it may interact with binding partners, DaliLite was 
utilized to align this domain with its closest structural neighbors: PP2A, karyopherin α, and 
Cand174.    
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Symplekin has the most structural similarity with human protein phosphatase 2A 
(PP2A) PR65/A subunit (1B3U, chain A); DaliLite aligned 104 Cα positions with a 1.7 Å 
RMSD and Z-score of 14.5 (Figure 3.8)79.   PP2A PR65/A forms a horseshoe shape that 
provides a scaffold for the regulatory and catalytic domains of PP2A, a heterotrimeric 
enzyme critical to regulation of many cellular functions71.  This protein has been classified as 
a HEAT domain and displays the classical cup shape for this type of repeat.  The main areas 
of difference in the structural comparison are the elongated helices 4A and 3B and the 
extended loop 8 of Symplekin.   Another interesting thing about this structural comparison is 
the much larger size of PP2A as compared with Symplekin.  However, as seen in Figure 2.1, 
Symplekin is predicted to have much more alpha-helical character than what is seen in the N-
terminal structure.  Thus, by looking at proteins that encompass a HEAT domain, we can start 
to think about how the rest of Symplekin may be positioned relative to the N-terminus. 
 Symplekin structurally superimposes on the structure of yeast karyopherin-α with 
11% identity over 196 Cα positions, a 5.0 Å RMSD, and a Z-score of 14.2. (Figure 3.9)74.   
The portion of karyopherin-α aligned with Symplekin has curvature of ~140° on the concave 
surface. The core of karyopherin-α is a canonical ARM repeat with an acidic concave surface 
equipped to bind the basic nuclear localization signal77. Symplekin aligns with the portion of 
karyopherin-α responsible for binding to nuclear localization signals (NLS), and both 
proteins share similar electrostatic potential on their concave face (Figure 3.10).  D. 
melanogaster karyopherin-α3 binds to the NLS of HSF1, and it has been reported residues 1-
124 of human Symplekin interacts with human HSF144,80.  The observation that karyopherin-
α3 and Symplekin contain similar structural motifs, have similar electrostatic surfaces, and 
bind to HSF1 support the hypothesis that both Symplekin and karyopherin-α are scaffolds for 
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protein-protein interactions.  However, with respect to loop 8, it is clear from the structural 
superposition of karyopherin-α and the Symplekin HEAT domain that the position of loop 8 
clashes with the position karyopherin-α uses to contact NLS sequences.  Thus, the details of 
complex formation may be distinct for the two proteins.  
 The third most structurally similar protein to Symplekin is Cand1 of the Cand1-cul1 
complex.  Cand1 is a protein responsible for scaffolding Cul1 and inhibits Cul1’s ability to 
form the E3 ubiquitin ligase complex.  Cand1 also uses its concave surface for protein 
binding (Figure 3.11).  Again, loop 8 is unique to Symplekin.  Examination of superpositions 
between the Symplekin HEAT domain and multiple other HEAT and ARM domain structures 
establish that, while many employ their concave surface for protein binding74, loop 8 is 
unique to the Symplekin structure.  
 
3.5 Structural implications for Symplekin in the mRNA processing complex 
 Residues 19-271 of D. melanogaster Symplekin form a canonical 5-HEAT repeat 
structure, with the exception of an extended loop 8 present in the Symplekins of known 
sequence. This is the first detailed structural information for any region of a Symplekin 
protein.  Sub-classification of Symplekin’s HEAT repeats and structural alignments indicate 
that Symplekin’s structure is consistent with other proteins that act as protein scaffolds.  
Multiple interactions can occur on a HEAT domain platform; crystal structures and 
molecular dynamics studies of importin-β reveal four regions for peptide binding within 5 
HEAT repeats 81.  Examination of the electrostatic potential of the HEAT domain shows that 
the concave surface is positively charged; indicating this surface is poised to bind negatively 
charged proteins.  In contrast, the ridge formed by even-numbered loops, including loop 8, is 
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negatively charged, thus allowing interaction with positively charged proteins (Figure 3.10). 
This is further evidence that this Symplekin HEAT domain is designed to accommodate 
multiple, diverse partners.  
 As mentioned in the Introduction, the N-terminal HEAT domain of Pta1 (yeast 
Symplekin) binds both Ssu72 and Glc7p33,45 and human Symplekin uses its N-terminus to 
bind HSF144.  Disruption of these interactions results in the abrogation of 3’-processing.  
Depletion of Glc7p causes an accumulation of phosphorylated Pta1 and reduction of 
polyadenylation, but can be rescued by adding the Glc7p phosphatase back into the 
processing reaction33.  Symplekin binding to Ssu72 promotes proper 3’-end processing and 
binding to HSF1 promotes polyadenylation of Hsp70 mRNA in heat stressed cells44,45.  Much 
of the literature regarding Symplekin suggest that it is a scaffold for assembling functional 
3’-processing machinery, namely CPSF and CstF subunits, but the interactions directly 
involving the HEAT domain appear to have more of a regulatory purpose.  Thus, we propose 
that the N-terminal HEAT domain of Symplekin acts as a regulatory scaffold for 3’ 
processing through interactions with phosphatases Glc7p and Ssu72 or transcription factors 
such as HSF1, while the C-terminal region is available for scaffolding and positioning the 3’-
end processing core proteins.  
 Structures of nearly all of the other core components of the 3’-end processing 
machinery have been determined, including CPSFs 30, 73, 100, CstF 64 and 77 and CF Im-
2516,82-84.  The electron microscopy image of purified 3’-end processing complex including 
Symplekin, CPSF, CstF and CFI was recently determined28.  This 50S complex displays a 
maximal dimension of 25 nm and exhibits a kidney shape, elongated and bent with two areas 
of high density and a cavity between them.  This length is likely dependent upon the 
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structural scaffolds within the processing complex, which literature shows are Symplekin and 
CstF 772,85.  The mouse CstF 77 structure exhibits a TPR domain, a domain similar to 
Armadillo and HEAT domains82.  CstF 77 uses its C-terminal Pro-rich region to bind to the 
CstF 50 and CstF 64, thus leaving the long TPR region available for binding other processing 
proteins26.  The CstF 77 TPR dimer is 16.5 nm in length2. Symplekin HEAT domain has a 
length of 6.5 nm, 25% of the total length of the EM image mRNA processing complex.  The 
armadillo C-terminal portion of Symplekin is likely much longer because it nearly twice the 
size of the HEAT domain (Figure 2.1).    The length and known binding partners of these two 
proteins support the idea that they make up the 25 nm length of the mRNA processing 
machinery visualized by EM.  Detailed crystal structures, electron microscopy images and 
small angle x-ray scattering of the 3’-end processing complex are all necessary for obtaining 
a complete understanding of the structure/function relationship within this macromolecular 
complex; the Symplekin HEAT domain reveals one more detailed piece of this structural 
puzzle.    
 
3.6 Figures and Tables  
Figures and tables are listed in the same order as they appear in the text of chapter 3. 
Figure 3.1 Overall structure of the Symplekin HEAT domain 
Figure 3.2 Extensive electrostatic interactions position Loop 8 over concave surface 
Figure 3.3 Alignment of individual HEAT repeats within the Symplekin HEAT domain 
Figure 3.4 Sequence alignment of Symplekin homologues from diverse species 
Figure 3.5 Sequence alignment of D. melanogaster Symplekin with higher eukaryotes 
 
Figure 3.6 Conserved residues in the hydrophobic core of Symplekin 
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Figure 3.7 Conserved residues on the concave and convex surfaces of Symplekin 
Figure 3.8 Symplekin structurally aligned with PP2A regulatory domain 
Figure 3.9 Symplekin structurally aligned with karyopherin-α 
Figure 3.10 Electrostatic potential of the concave face of Symplekin and karyopherin-α 
Figure 3.11 Symplekin structurally aligned with Cand1 
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Figure 3.1 Overall structure of the Symplekin HEAT domain 
Illustration of the HEAT domain of the N-terminal region of Symplekin.  The termini are 
labeled and the coloring is in rainbow (red, orange, yellow, green, blue, and purple) from N 
to C terminus.  HEAT repeat helices (A and B) are in the same color, but with the concave 
helix in a lighter shade.  Helices are assigned letters and numbers based on the accepted 
method for naming HEAT repeats.  A helices make up the convex surface and corresponding 
B helices in each repeat make up the concave surface.  Loop 8 is shown in cyan, while all 
other loops connecting intra- and inter-HEAT repeats are gray. 
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Figure 3.2 Extensive electrostatic interactions position Loop 8 over concave surface  
Loop 8 is held in position by many electrostatic interactions.  Concave surface residues R258 
and K132 use their side chain nitrogen atoms to form contacts within Loop 8 through D201/ 
S203 and G200, respectively.  M257 also contacts Loop 8 through S195.  Many contacts 
within the loop also appear to be important to maintain its fold.  
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Figure 3.3 Alignment of individual HEAT repeats within the Symplekin HEAT domain  
(A) Structural alignment of each HEAT repeat within Symplekin.  Helix 3B is much longer 
and has a unique bend relative to the other B-helices. (B) D19 and R25 of repeats 2 and 4 are 
residues well conserved in HEAT repeats and help define the structure as a HEAT domain. 
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H. sapiens DIELLLKLI-ANLNM-LLRDEN----VNVVKKAILTMTQ-LYKVALQWMVKSRVISELQEA-C---WDMVSAMAGD--II
X. laevis DNELLIKLI-ANLHM-LLKDEN----VNVVKKSILTMTQ-LYKVALQWVARSRPPSEQQES-C---WDLVTEMAAD--IL
D. melanogaster KVELLPHVI-NVVSM-LLRDNS----AQVIKRVIQACGS-IYKNGLQYLCSLMEPGDSAEQ-A---WNILSLIKAQ--IL
S. purpuratus DNQMLCTVL-PRLHM-MLTEENQP--AAVLKRVILCTSQ-LYRVTIKWLAGVKVLQEDMEA-G---WAALMLMKKK--IV
C. elegans DFTLCNKTV-ERYSFYLIPNKSIKRYESVIKRVVVASTN-LYPIVLEF-A-IMDKNDNAES-C---WDAFNLLKNR--IC
S. cerevisiae AQSTADVLVYKNIVL-IMCASY----PLVLDLVAKTSNQEMFD-QLCMLK-KFVLS-HWRT-A---YPLRATVDDETDVE
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Figure 3.4 Sequence alignments of Symplekin homologues from diverse species 
Sequence alignment of the N-terminus of several Symplekin homologues annotated with the 
secondary structural elements resolved in the structure of D. melanogaster Symplekin HEAT 
domain.  Species include H. sapiens, X. laevis (frog), S. purpuratus (sea urchin), C. elegans 
(worm), S. cerevisiae (yeast), and A. thaliana (plant).  Polar residues are in green, charged 
polar residues are blue, hydrophobic residues are black.  Black triangles denote residues 
found to make electrostatic interactions with concave surface residues in the crystal structure.  
Numbers on the top of the sequence correspond to the D. melanogaster residues. 
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Drosophila -ATARAKVVDWCNELVIASPSTKCELLAK-VQETVLGSCAELAEEFLESVLSLAHD-SNM 57
Xenopus --------------------------MLKQVQELIINKDPTLLDNFLDEIIAFQADKS-V 33
Mus DGMTTSERVVDLLNQAALITNDSKITVLKQVQELIINKDPTLLDNFLDEIIAFQADKS-I 59
Homo DGMTTSERVVDLLNQAALITNDSKITVLKQVQELIINKDPTLLDNFLDEIIAFQADKS-I 59
Drosophila EVRKQVVAFVEQVCKVKVELLPHVI-NVVSMLLRDNSAQVIKRVIQACGSI-YKNGLQYL 115
Xenopus EVRKFVVNFIEEACKLDNELLIKLIANLHMLLKDENVNVVKKSILTM--TQLYKVALQWV 91
Mus EVRKFVIGFIEEACKRDIELLLKLIANLNMLLRDENVNVVKKAILTM--TQLYKVALQWM 117
Homo EVRKFVIGFIEEACKRDIELLLKLIANLNMLLRDENVNVVKKAILTM--TQLYKVALQWM 117
Drosophila C-S-LMEPGDSAEQAWNILSLIKAQILDMIDNENDGIRTNAIKFLEGVVVLQS--FADED 171
Xenopus ARSRPP--SEQQESCWDLVTEMAADILLLLESDNDGIRTHAVKFVESLIVTLSPRTPDSE 149
Mus VKSRVI--SDLQEACWDMVSSMAGEIILLLDSDNDGIRTHAIKFVEGLIVTLSPRMADSE 175
Homo VKSRVI--SELQEACWDMVSAMAGDIILLLDSDNDGIRTHAIKFVEGLIVTLSPRMADSE 175
Drosophila SLKR-DGDFSLAD-VP-DHCTLFRR-EKLQEEGNNIL-DILLQFHGTTHISSVNLIACTS 226
Xenopus VPKRQEGDISL-EQIPSDHA--FLKYNTLRDVGKQAVKELL-KFMAHPAISSINLTAALG 205
Mus VPRRQEHDISL-DRIPRDHP--YIQYNVLWEEGKAAV-EQLLKFMVHPAISSINLTTALG 231
Homo IPRRQEHDISL-DRIPRDHP--YIQYNVLWEEGKAAL-EQLLKFMVHPAISSINLTTALG 231
Drosophila SLCTIAKMRPIFMGAVVEAFKQ 248
Xenopus SLASIARQRPMFMAEVIQAYET 227
Mus SLANIARQRPMFMSEVIQAYET 253
Homo SLANIARQRPMFMSEVIQAYET 253
α1A α1B α2A
α2B α3A α3B
α4A α4B
α5A α5B
α6A
loop 8
 
Figure 3.5 Sequence alignment of D. melanogaster Symplekin with higher eukaryotes 
 
Sequence alignment of D. melanogaster Symplekin protein with X. laevis, M. musculus and 
H. sapiens.   Secondary structural elements corresponding to the HEAT domain of N-
terminal Symplekin are listed above corresponding residues.  Gray bars indicate areas of 
conservation.   
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Figure 3.6 Conserved residues in the hydrophobic core of Symplekin 
Residues shown in stick representation and colored purple are residues that are highly 
conserved among Symplekin homologues (See Figure 3.5) and that fall into the hydrophobic 
core of the N-terminal Symplekin HEAT domain.  All other regions of the protein are gray 
and the termini are labeled.  The hydrophobic core is essential for maintaining the bi-helical 
fold of HEAT repeats. 
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Figure 3.7 Conserved residues on the concave and convex surfaces of Symplekin 
The surfaces of Symplekin are rendered with color representing conservation.  (A) Looking 
at conserved residues projecting from the concave surface, yellow on helices, cyan in loop 
regions (B) Looking at the convex surface, green residues are conserved.  The concave 
surface contains many more conserved residues than does the convex surface.  Also, loop 8 
contains many conserved residues.  This suggests that the concave surface may be more 
important than the convex surface for Symplekin’s biological scaffold function.
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Figure 3.8 Symplekin structurally aligned with PP2A regulatory domain 
Symplekin (colored as in Fig. 3.1) overlaid with PP2A PR65/A regulatory domain in gray 
(PDB 1b3u, chain A).  A closer inspection of the area where Symplekin aligns shows that 
loop 8 is unique from the other loops in both structures.  Also, α4A and α3B have extended 
helices relative to the other HEAT repeats.  Loop 8 packs against this longer α3B helix.  
PP2A regulatory domain is a scaffold for the PP2A phosphatase activity, and it’s structural 
similarity to Symplekin may indicate that Symplekin can also provide this regulatory scaffold 
function.  
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Figure 3.9 Symplekin structurally aligned with Karyopherin-α 
Symplekin shown in rainbow, Karyopherin-α in gray, nuclear localization peptide bound to 
Karyopherin-α surface in magenta.  Close inspection of this structural alignment indicates 
that Symplekin loop 8 (cyan) lies in the same region that is Karyopherin uses to bind to 
nuclear localization peptides.  This overlay illustrates the ability of the concave surface of 
these types of structural domains to be used as binding surfaces.   
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Figure 3.10 Electrostatic potential of the concave face of Symplekin and karyopherin-α 
Red areas indicate regions of negative charge, while blue regions correspond to areas of 
positive charge.  The ridge formed by loop 8 and the other even numbered loops in 
Symplekin have a negative charge (red), while the concave surface is mainly positively 
charged (blue). The region of negative charge (red) on karyopherin-α is used to bind 
positively charged, lysine/arginine-rich nuclear localization signals.  The distribution of 
charge on Symplekin’s surfaces may be important for its ability to bind to multiple diverse 
proteins. 
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Figure 3.11 Symplekin structurally aligned with Cand1 
Helical representation of Symplekin colored as in Fig 3.1, Cand1 in gray, Cul1 in white.  
Rotating the structure 90° forward and cutting away the regions that don’t align; the 
structures show that loop 8 is a unique extended loop that lines up against helix α3B.  As in 
Figure 3.8 and 3.9, it is clear that HEAT domains can be used to scaffold other proteins and 
the extended loop 8 is unique to Symplekin. 
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Chapter 4. Biophysical characterization of the Symplekin HEAT 
domain through molecular dynamics simulations 
 
4.1 Why use molecular dynamics to study Symplekin? 
 Molecular dynamics (MD) simulations have become an increasingly popular method 
to understand how a molecule’s motion is tied to its biological function.  Specifically, 
simulations with exportin Cse1p, a HEAT domain protein, provide a picture of a possible 
intermediate state between the crystal structures of the RanGTP bound and unbound states72.  
Another MD study shows that importin-β unfolds from it’s 9 nm length to 15 nm length 
when its ligand is removed73.  Focusing on the hydrophobic core of armadillo and HEAT 
repeats, Parmeggiani et al. utilized molecular dynamics to find the most energetically 
favorable core and modular peptide-binding motifs86.  Each of these examples provides 
evidence for the valuable use of molecular dynamics simulations to gain an understanding of 
how energy and motion are intimately tied to the biological function of macromolecules. 
 Through solving the structure of the Symplekin HEAT domain, I have demonstrated 
that this protein indeed has the structure of a molecular scaffold.  This scaffolding role of 
Symplekin was predicted because Symplekin can bind to a variety of proteins and has been 
implicated in regulating the orientation of the CPSF and CstF complex for 3’-end mRNA 
processing (see Figures 1.1, 1.3 and Table 1.1).  I sought to strengthen the argument that 
Symplekin is a molecular scaffold by studying its motion through MD.  I used MD to 
investigate the overall magnitude of motion for the HEAT domain and also to appreciate how 
motions within this domain are correlated to each other.  Second, I wanted to probe the 
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importance of the conserved loop 8 region of the molecule and observe its effect on the 
overall motion of the molecule.  These MD studies help to explain how the HEAT domain of 
Symplekin is energetically poised to bind to multiple protein partners.  
 Molecular dynamics is a method that uses computer simulations that are guided by 
laws of physics, mathematics and chemistry.  An initial velocity and position is assigned to 
each atom in the molecular model, and the interaction (force and position) between all atoms 
is monitored over a given time period.  Nanosecond time scale simulations allow us to see 
how a molecule breathes.  Femto- through pico-second timescales are used to see bond 
stretching and angle bending, while pico- through nanosecond timescales are the timescales 
used to see surface side chain motion, loop motion and collective motion.  The theory of MD 
is based on Newtonian physics and statistical mechanics.  I am not an expert in either physics 
or statistical mechanics, so I collaborated with Monica Frazier on the MD studies of 
Symplekin.  She has studied these topics and has published a peer-reviewed article with Matt 
Redinbo using this technique. 
 
4.2 Design of Symplekin mutants for molecular dynamics 
 Three initial structural models were utilized in the molecular dynamics simulations.  
These include wild-type, short modeled loop 8 and poly-ser loop 8, as illustrated in Figure 
4.1. Only the region of loop 8 was modified in these structures, the rest of the molecule 
remained the same.  The reason for making the two mutant forms of loop 8 was to probe the 
importance of the presence of the loop, and also the presence of specific charged residues 
within the loop.  These simulations will demonstrate the importance of this conserved feature 
on the energetic profile of the molecule. 
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 To understand how the presence of loop 8 affects the magnitude and correlation of 
motions in the Symplekin HEAT domain, loop 8 was replaced with a loop having 
characteristics of other inter-helical loops in HEAT domains.  To design a linker that would 
not disrupt the overall motion of the core HEAT helices, the distance between the Cα termini 
of α4B and α5A was determined and maintained in the mutation; the length between leucine 
187 and arginine 216 of wild type Symplekin is 10.6 Å.  To select a linker, many other 
HEAT and Armadillo proteins were examined to identify common inter-helical linkers of 
10.6 Å length.  Six residues were repeatedly used to bridge a 10.6 Å gap in HEAT repeats.  
To keep this linker as authentic as possible, native residues were reserved on each end of the 
loop and connected with a residue common to most loops, glycine.  The linker was designed 
and mutated in silio using COOT61 as 187-LQSGRR-216.  This short linker connects α4B 
with α5A and replaces the lengthy charged loop 8.  During the following discussion, this is 
referred to as the “short loop 8” and is considered to be a conventional loop to connect 
HEAT repeats. 
 The second mutation of loop 8 was designed to study the importance of specific ionic 
interactions both within the loop and between the loop and concave surface.  Thus, polarity 
was maintained, but the specific ionic interactions were disrupted by mutation of charged 
residues to serine.   D192, E193, D194, K197, R198, D199, D201, D209, H210, R215 were 
all computationally mutated to serine. This mutant will be referred to as the “Poly-Ser loop 
8”.  Each model was subject equilibration before MD; this step will allow the models to find 
a low energy equilibrium state87.   
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4.3 Molecular dynamics simulations methods  
 In collaboration with Redinbo lab member Monica Frazier, molecular dynamics 
simulations of the Symplekin HEAT domain, including wild type, modeled loop 8 and poly-
ser loop 8 were performed using the AMBER 2003 force field with at 2 fs time step, with a 
total run time of 15 ns87.  Several programs within AMBER were utilized for setting up the 
simulations.  LEaP was used to generate the topology and parameter files, SANDER 
performed the 5000 steps of energy minimization, which included constant volume followed 
by constant temperature equilibration, the PMEMD module was used for the production runs, 
and PTRAJ was utilized for analysis of the results87.  TIP3P water molecules were used to 
generate the solvated structure88, and electrostatic interactions were calculated using the 
particle-mesh Ewald algorithm with a cutoff of 10 Å applied to Lennard-Jones interactions89.  
All molecular dynamics simulations were modeled after the previous simulations performed 
in the Redinbo laboratory90.  
 
4.4 Result of molecular dynamic simulations support Symplekin’s role as a scaffold  
 The first step in analysis of the MD simulations is to make sure that each simulation 
reached equilibrium.  Root mean squared deviations (RMSD) of C-α peptide backbone atoms 
(Figure 4.2A) and all atoms (Figure 4.2B) do not fluctuate significantly after 5 ns in any of 
the simulations.  Thus, the data between 5-15 ns were utilized for analysis, and the first 5 ns 
were discarded.  Examination of the atomic position fluctuation shows that the loop regions 
of the protein have the largest change in position, especially loop 8 (residues 187-216) 
(Figure 4.3). It is not surprising that most of the residues in the helices have lower 
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fluctuations because they are held in place by an extensive hydrophobic network in the 
interior of the protein, as can be seen in Figure 3.6.  The overall magnitude of Cα atomic 
position fluctuations (apf) Å2 for each simulation confirms that the wild-type and poly-ser 
models have a similar level of motion, but the short modeled loop has a 20% increase in 
average fluctuation (Table 4.1).   The apf was calculated with and without the terminal 
residues because untethered termini typically exhibit more fluctuation.  In this case, however, 
the termini did not significantly add to the overall motion.  Upon closer inspection, the 
residues in the canonical modeled short loop have a 0.5 Å2 increase in apf compared to the 
poly-ser or wild-type loops, even thought the short loop is only composed of 6 residues 
versus the 29 residues in the wild-type loop.  The presence of loop 8 is dampening the level 
of motion throughout the whole molecule.      
 Besides looking at the magnitude of motions between the simulations, we can also 
examine the way the movements are correlated within the protein by examining correlation 
plots.  Correlation plots have each residue plotted on the x and y axis, so that the 
interdependence of movement can be compared between each set of residues.  The plot of 
wild-type Symplekin residues shows correlated movements in the core of the protein and 
anti-correlated motion at the termini (Figure 4.4).  In other words, the core of the protein 
moves together as one unit, while the termini are able to move in opposite directions from the 
core.  The modeled short loop Symplekin simulation shows the same areas of correlated and 
anti-correlated motion, but the level of correlation has greatly increased (Figure 4.5).  
Increased correlated movement means fewer degrees of freedom for the protein to sample 
conformational states.  Since Symplekin has multiple binding partners, the motion within the 
molecule should allow docking of many different proteins.  Thus, it appears that loop 8 is 
58 
 
dampening the overall correlated movements in this HEAT domain, which allows this 
scaffold flexibility for its diverse binding partners. The wild type and poly-ser Symplekin 
correlation plots display the same areas and levels of motion (Figure 4.6 and Table 4.1).  
This indicates that the presence of lengthy loop 8 dampens the overall motion of the HEAT 
domain, but specific residues in the loop are not essential for this dampening motion.   
 
4.5 Key electrostatic interactions are maintained during MDS  
 To further understand the role of loop 8, the electrostatic interactions holding the loop 
in place in the crystal structure (Figure 3.6) were examined throughout the dynamics 
simulations.  Over each 0.002 fs time step in the simulation, the distance between each set of 
atoms making electrostatic contacts in the crystal structure was examined.  Table 4.2 lists 
each of the atomic distances that were investigated in the wild-type simulation.  The 
distances monitored over the simulation time-course are shown in Figures 4.7, 4.8 and 4.9.  
(Time shown in figures represents the 10 ns after the 5 ns equilibration time.  See beginning 
of this section for explanation.)   
 K132, the only residue on alpha helix 3B that has electrostatic interactions with loop 
8 in the crystal structure, does not maintain these contacts during the simulation (Figure 
4.7A).  However, the G200-K132 residues stay within 5 Å for the last 8 ns of the simulation, 
after their distance reaches a maximum of 11 Å.  This implies that this part of the loop 
maintains close proximity with helix 3B.  Loop 8 S195 does not maintain close contact with 
helix 5B M257, nor does loop 8 S203 and helix 5B R258 (Figure 4.7 B, C).  However, since 
the overall apf for loop 8 is low, there is not a large movement away from the position seen 
in the crystal structure. 
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 Select interactions between residues within loop 8 do maintain close proximity during 
the simulation (Figure 4.8).  These include serine 203 interacting with aspartic acid 206 and 
aspartic acid 192 interacting with serine 195.  These observations indicate that loop 8 is 
moving in a directed manner and some interactions within the loop may be important in 
maintaining its position for its protein binding functions.  This could be tested by making 
these four residues nonpolar and performing protein binding assays.   Also, residues arginine 
258 and methionine 257 in loop 10 maintain proximity through an electrostatic interaction, 
indicating that the backbone oxygen on methionine 257 is purposefully projecting arginine 
amine groups towards loop 8.  In this way, the core HEAT domain is communicating with 
loop 8.   
 Another interesting observation about arginine 258 is that it maintains close 
proximity to aspartic acid 201; this contact seen in the crystal structure is maintained 
throughout the simulation (Figure 4.9).  Both aspartic acid 201 and arginine 258 are 
conserved among Symplekin homologues in divergent species (Figure 3.4).  Mutations of 
conserved residues D201 and R258 would be very interesting to monitor in a protein binding 
assay.  As discussed in the following chapter, Dr. Mindy Steiniger is continuing to develop a 
biochemical assay for testing protein-protein interactions with Symplekin.    Surely, abolition 
of this key electrostatic interaction would have an impact on the loop’s contribution for 
protein binding.  (Replications of each of these molecular dynamics simulations is currently 
underway and will be incorporated into the final version of this dissertation.) 
 
4.6 Molecular dynamics summary 
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 Loop 8 dampens the overall motion and the correlated motions within the Symplekin 
HEAT domain.  These results suggest that loop 8 encourages a more stable binding surface 
for protein interactions.  Also, loop 8 increases the degrees of freedom for movement 
correlation, improving the HEAT domain’s flexibility to bind to multiple partners.  Key 
interactions between loop 8 residues and the concave helices are maintained and no large 
movements of the loop are seen during the simulations, indicating that it may maintain it’s 
proximity to the concave surface to for its biological function as a protein scaffold.   
  
4.6 Figures and Tables 
Figures and tables are listed in the same order as they appear in the text of chapter 4. 
 
Figure 4.1 Loop region of Symplekin HEAT domain for three independent molecular 
dynamics simulations 
 
Figure 4.2 Root mean squared deviation of atom positions over time scale of molecular 
dynamics simulations 
 
Figure 4.3 Atomic position fluctuation of each Cα position 
Table 4.1 Average, maximum and minimum atomic position fluctuations for each molecular 
dynamics simulation 
 
Figure 4.4 Symplekin wild-type correlation plot and structural implications 
Figure 4.5 Correlation plot of Symplekin with the short modeled loop 8 
Figure 4.6 Correlation plot of Poly-Ser loop 8 mutant Symplekin 
Table 4.2 List of atoms with electrostatic interactions in the crystal structure 
Figure 4.7 Electrostatic interactions disrupted during simulation 
Figure 4.8 Electrostatic interactions maintained during the wild-type simulation 
Figure 4.9 Arginine 258 remains in close proximity to aspartic acid 201 during the wild type 
molecular dynamics simulation. 
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Figure 4.1 Loop 8 region variants of the Symplekin HEAT domain used in three 
independent molecular dynamics simulations 
 
(A) Wild-type Symplekin with native residues in loop 8 region.  The residues that are later 
mutated to serine are shown in stick representation.  Helices are labeled and colored the same 
way as previously described in Figure 3.1. (B) Poly-Ser loop 8 modeled by changing loop 8 
residues shown in sticks into serine.  (C) Short loop 8 model prepared by removing residues 
191-214 and joining native residue 189 and 215 by placing a glycine residue at position 190.  
This represents a canonical inter-helical loop found in HEAT domains.   
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Figure 4.2 Root mean squared deviation of atom positions over the time scale of the MD 
simulations 
 
(A) Cα RMSD and (B) all atoms RMSD over 15 ns molecular dynamics simulation. Boxed 
regions denote the time span of the simulations used in data analysis. These two figures 
demonstrate that all three models used in the MD simulations came to equilibrium at the 
beginning of the production run.  It is important to select a constant time frame to compare 
the three models correctly.  
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Figure 4.3 Atomic position fluctuations of each Cα position 
The x-axis represents the Cα atome of each residue and the y-axis is the atomic position 
fluctuation of that Cα atom in Å2.  The area of highest fluctuation is loop 8 (187-216) in all 
cases.  The majority of helices have lower than 1 Å2 fluctuation.   Helical regions are 
typically less dynamic than loop regions, and that can be seen here. 
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Table 4.1 Average atomic position fluctuations (Å2) for three replicates of the MD 
simulations 
 
Cα Atoms  Wild‐Type Loop 8 Poly‐Ser Loop 8  Short  
Loop 8  
Loop 8 Cα only  1.213±0.035  1.430±0.318  1.682±0.040  
All Cα  1.024 ±0.024  1.100±0.087  1.162±0.036  
Non Loop 8 Cα  0.998±0.032  1.053±0.056  1.150±0.046  
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Figure 4.4 Symplekin wild-type correlation plot and structural implications 
Correlation plot shows regions of correlated (red) and anti-correlated (blue) motions.  The X-
and Y-axes represent each residue in the wild-type structure.  The bars are colored according 
to their assigned secondary structural elements as shown in the structure (Figure 2.1).  The 
central portion of the plot shows that the three middle HEAT repeats display correlated 
movement.  The scale shows the relative intensity of the correlation.  Therefore, regions of 
yellow still have motion, but are not correlated or anti-correlated movements. 
66 
 
Wild-Type Short Modeled Loop 8
 
Figure 4.5 Comparison of wild-type and short modeled loop 8 correlation plots 
The correlation plots of wild-type and short modeled loop 8.  Red areas are correlated and 
blue areas are anti-correlated.  The scale is the same as in Figure 4.4.  Again, the central 
region of the protein, HEAT repeats 2, 3 and 4 move in correlated motion, while the termini 
move in an anticorrelated motion with the central portion.  All motions have greater 
relationships in model where Loop 8 has been removed and replaced with a loop typically 
found in HEAT domains.  The presence of Loop 8 effects the motion relationships within the 
protein. 
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Figure 4.6 Correlation plot of Poly-Ser loop 8 mutant Symplekin 
Correlation plot of Poly-Ser loop 8 mutant Symplekin with each residue on the x and y axis.  
Red indicates correlated movement and blue represents anti-correlated movements.  The 
scale of correlation is the same as in Figure 4.4.  This plot is very similar to the level of and 
arrangement of motions seen in the wild-type MD simulation.  It appears that the presence of 
loop 8 and perhaps not the identity of the residues within the loop are important for motion 
relationships within the Symplekin HEAT domain. 
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Table 4.2 List of atoms with electrostatic interactions in the crystal structure 
Name Residue Atom name Atom # Name Residue Atom name Atom number
LYS 132 1HZ 1745 GLY 200 O 2791
LYS 132 2HZ 1746 GLY 200 O 2791
LYS 132 3HZ 1747 GLY 200 O 2791
SER 203 H 2825 ASP 206 OD1 2872
SER 203 H 2825 ASP 206 OD2 2873
ARG 258 1HH1 3693 SER 203 OG 2831
ARG 258 2HH1 3694 SER 203 OG 2831
ARG 258 1HH2 3696 SER 203 OG 2831
ARG 258 2HH2 3697 SER 203 OG 2831
ARG 258 1HH1 3693 ASP 201 OD1 2800
ARG 258 2HH1 3694 ASP 201 OD1 2800
ARG 258 1HH2 3696 ASP 201 OD1 2800
ARG 258 2HH2 3697 ASP 201 OD1 2800
ARG 258 1HH1 3693 ASP 201 OD2 2801
ARG 258 2HH1 3694 ASP 201 OD2 2801
ARG 258 1HH2 3696 ASP 201 OD2 2801
ARG 258 2HH2 3697 ASP 201 OD2 2801
ARG 258 1HH1 3693 MET 257 O 3675
ARG 258 2HH1 3694 MET 257 O 3675
ARG 258 1HH2 3696 MET 257 O 3675
ARG 258 2HH2 3697 MET 257 O 3675
SER 195 HG 2705 MET 257 O 3675
ASP 192 H 2659 SER 195 OG 2704
Atom 1 Atom 2
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Figure 4.7 Electrostatic interactions disrupted during simulation 
 
Each graph shows the change in distance vs. time, with the specific atoms listed in the 
legend. (A) Distance between each hydrogen atom attached to the side-chain nitrogen of 
K132 and the oxygen from the main-chain oxygen of G200. (B) Distance between Hγ of 
S195 and main-chain Oγ of M257. (C) Four hydrogens on R258 side chains do not maintain 
electrostatic interaction with Oγ of S203.  Since these interactions are disturbed during the 
simulations, perhaps they are less important for anchoring loop 8 in position at the end of 
HEAT repeats 3, 4 and 5.   
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Figure 4.8 Electrostatic interactions maintained during the wild-type simulation 
Change in distance vs. time for three electrostatic interactions found in the crystal structure. 
The distances shown on this graph demonstrate that specific electrostatic interactions remain 
within close proximity during the wild-type MD simulation.  Serine 203 remains within a 
few angstroms of aspartic acid 206, aspartic acid 192 and serine 195 also maintain close 
proximity.  These sets of residues maintain electrostatic interactions within loop 8 during the 
10 ns MD simulation.  R258 and M257 also maintain close distance, but this might be due to 
their proximity in loop 10. 
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Figure 4.9 Arginine 258 remains in close proximity to aspartic acid 201 during the wild 
type molecular dynamics simulation 
 
Change in distance vs. time for three electrostatic interactions found in the crystal structure. 
This key interaction between conserved residues arginine 258 and loop 8 aspartic acid 201 is 
maintained throughout the MD simulation, as can be seen here by monitoring the distance 
between hydrogens on the arginine and the two aspartic acid oxygens.  Thus, loop 8 may be 
using D201 to anchor to loop 10 R258.   
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Chapter 5: Preliminary assays and preparation of 
Symplekin mutants for biochemical characterization 
 
5.1 Introduction to biochemical characterization of Symplekin 
 As outlined in chapter one, Symplekin plays a role in 3’-end mRNA processing and 
has been found at cellular tight junctions.  Because Symplekin is involved with processes 
involving RNA modification and the HEAT domain is predicted to be structurally similar to 
RNA-binding protein Pumilio, I probed the RNA binding activity of the Symplekin HEAT 
domain using fluorescence polarization.  No interaction with RNA was detected, and all 
literature on Symplekin thus far has not indicated any RNA binding role.   
 Symplekin binds numerous proteins as has been shown through pull-down assays, 
immunofluorescence and immuno-precipitation (Table 1.1).  Most of these interactions 
utilize full length Symplekin protein.  HSF1, Ssu72 and Glc7p  are the only proteins that 
have been shown to bind specifically to the N-terminus of Symplekin; hHSF1 binds to the 
first 125 residues of human Symplekin, yeast Ssu72 binds to the first 300 residues of Pta1, 
while Glc7p interacts with residues 100-200 of Pta133,44,45.   To probe binding partners, I 
worked in collaboration with Dr. Mindy Steiniger of the Marzluff laboratory at UNC-CH on 
development of pull-down binding assays.  Her goal is to work with D. melanogaster 
proteins and reconstitute the full length and HEAT domain Symplekin interactions with 
homologues of HSF1, Ssu72, CPSF73 and CstF-64.  Mindy is currently developing the 
protein-binding interactions through pull-down assays and histone processing reactions; I 
show some of our initial results in this chapter.  Finally, at the end of the chapter, I discuss 
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the preparation of several mutations within the Symplekin HEAT domain for testing in the 
finalized protein binding assay.  
 
5.2 Initial nucleic acid binding assays for Symplekin are inconclusive  
 SVM-prot, an online tool that identifies protein function, indicated that Symplekin 
may bind RNA, predicted with an R-value of 1.4 and P value of 71.3%91.  Symplekin has 
striking similarity to the RNA-binding Pumilio family of proteins: Z-score of 9.5 over 160 
aligned residues with an RMSD of 3.1 Å75,79 (Figure 5.1).  Fluorescence polarization assays 
were performed to test the hypothesis that Symplekin’s HEAT domain binds to RNA.  
Assays were developed based on the fluorescence anisotropy experiments of LeTilly et al. 
and those of Aviv et al92,93. 
 Examination of the alignment indicates that the specific Pumilio residues 
participating in RNA-binding are not conserved in Symplekin, so it is unlikely that they 
would bind to the same RNA sequence.  5’-Fluorescein-labeled RNA substrates including a 
10 nucleotide sequence mimicking the Pumilio-binding RNA sequence, a 29 nucleotide 
stem-loop sequence conserved within histone mRNA, and a random 30 nucleotide sequence 
(also containing a stem-loop) were utilized in an fluorescence polarization binding assay with 
Symplekin 19-271 (Table 5.1).  Fluorescein absorbs at 485 nm and emits at 520 nm, so a 
change in anisotropy can be detected by monitoring the change in absorption and emission at 
these wavelengths.  A 5’-fluorescein-labeled 15-mer DNA strand was used in place of the 
RNA as a negative control reaction.   
 During the assay, the concentration of nucleic acid was held constant at 10 or 100 
nM, while the protein concentration ranged from 150 µM to 0.001 µM.  The Symplekin 
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HEAT domain protein was purified as outlined in chapter 2. The buffer for the binding assay 
was 20 mM HEPES, pH 7.4, 0.1 mM NaCl, 0.1mM EDTA and 20% glycerol.  The buffer, 
protein and substrate were added to a 384-well plate and gently spun down to remove any air 
bubbles.  The solutions were allowed to sit for 2 minutes and then the anisotropy 
measurements were read using the BMG Pherastar.     
Figure 5.2A displays a preliminary binding assay to determine the ideal range of 
protein concentrations to examine.  The substrates (15-mer DNA and the mmu RNA, see 
Table 5.1) in this figure are held at 10 nM.  No significant change in anisotropy is seen until 
Symplekin protein levels reach 0.25 µM.  Also, it appeared that perhaps there was a 
difference between the RNA and the DNA binding profiles at higher protein concentrations; 
however change in anisotropy was very minimal. Another assay was performed to validate 
this result, utilizing higher concentrations of protein.  To ensure enough time for binding, 
during the second round of assays, the nucleic acid and protein were combined in the plate 
and allowed to incubate for 30 minutes before testing.  Figure 5.2B shows that there is no 
binding of Symplekin HEAT domain to any substrate.  A proper binding curve would show 
an increase in fluorescence units as the Symplekin HEAT domain protein concentration is 
increased.  The results are erratic in each run, indicating the results are not corresponding to a 
binding event.  Also, there is no positive control reaction to validate the assay, so no 
conclusions can be drawn from these initial experiments.  The nucleic acid substrates and 
proteins are available for further experiments and the Pumilio protein can be used as a 
positive control protein. 
  The RNA-binding function predicted by SVM-prot was no doubt based on the fact 
that Symplekin and Pumilio contain similar structural motifs. Throughout my literature 
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search and structural alignment work, the majority of proteins with HEAT repeats bind to 
proteins, not nucleic acids.  Also, the interactions between the conserved sequences in the 3’-
end of messenger RNA already have well documented protein binding partners. This 
underwhelming RNA binding data, taken together with known protein-protein interactions 
between Symplekin and CstF64, CstF77, CPSF73, ZONAB,HSF-1, Ssu72 and many others 
(Table 1.1) indicate that the Symplekin is poised for protein binding and not RNA binding. 
 
5.3 Preliminary pull-down assays to characterize Symplekin interactions with its 
putative protein binding partners 
 The GATEWAY system was utilized for cloning Symplekin’s multiple putative 
protein binding partners.  This system from Invitrogen utilizes a pENTR vector that is useful 
to shuttle the gene to different functional plasmids.   Thus, the versatility of the pENTR 
vector will be advantageous for studying recombinant proteins and in vivo experiments for 
investigation of mRNA processing reactions.  For preparation of recombinant protein 
interaction assays, the pENTR clones were shuttled to the pEXP2 vector that provides a C-
terminal 6xHis tag.  Table 5.2 shows the list of constructs that are in various stages of 
cloning into the pENTR vector and shuttled to the pEXP2 vector.   Original cDNA for 
cloning was supplied by Deirdre Tatomer in the Biology Department of UNC-CH and the 
cloning and expression were done in collaboration with Dr. Mindy Steiniger in Dr. William 
Marzluff’s laboratory at UNC-CH. 
 Since these proteins are all of eukaryotic origin, they were expressed in an in vitro 
translation system that couples transcription and translation (TnT, Promega).  This cell-free 
method utilizes crude extracts from rabbit reticulocyte lysate that contain all the components 
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required for translation and a prokaryotic phage RNA polymerase for transcription from 
plasmid DNA.  Radio-labeled amino acids were utilized in the media as a method to detect 
protein expression because protein yield is only a few nanograms per 50 uL reaction.  Figure 
5.3 illustrates the TnT expression of three CstF64 constructs and full length ssu72.   
 In collaboration with Dr. Mindy Steiniger, pull-down assays were carried out to 
assess the ability of the HEAT domain to interact with the TnT expressed proteins.  
Recombinant Symplekin HEAT domain tagged with N-terminal 6xhis-MBP was purified 
(see chapter 2) and added to amylose resin for MBP binding.  CstF64 and Ssu72 proteins 
prepared through TnT were added to separate batches of recombinant MBP-Symplekin 
bound to amylose.  Proteins were incubated for at least 30 minutes in PBS buffer.  Reactions 
were then batch washed 3 times and eluted with SDS or PBS-maltose.  Unfortunately, both 
Symplekin HEAT domain and MBP-only controls showed interactions with ssu72 and 
CstF64 constructs (Figure 5.4A).   More salt was added to the binding and wash buffer in an 
attempt to reduce the non-specific MBP protein binding to the TnT expressed protien.  
However, the same level of binding was seen with MBP or MBP-Symp 19-271 even with up 
to 300 mM NaCl added to the binding buffer (Figure 5.4B).   This amylose-MBP pull-down 
was an ineffective method to examine interactions between Symplekin 19-271 and ssu72 or 
CstF64 constructs.  Utilizing a method that does not include MBP or amylose was the next 
course of action. 
 The next round of binding assays were attempted using full length N-terminal GST 
tagged Symplekin. This time, Symplekin was bound to GST resin and the pull-downs were 
performed in a similar manner, except proteins were incubated for several hours in PBS 
buffer, PBS buffer plus 1M NaCl, or PBS buffer plus 0.1% CHAPS.  The protein was eluted 
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with PBS plus glutathione.  During this round, CPSF73, full length CstF64 and CstF64-hinge 
were tested for binding to full-length Symplekin (Figure 5.5).  Symplekin and CstF64 were 
shown to co-immunoprecipitate in human cells, so this interaction was thought to be a 
positive control to validate this assay26.  Again, the GST only negative control reaction also 
shows interaction with the TnT expressed proteins.  Unfortunately, up to this point, we have 
been unable to positively identify any protein binding partners for Symplekin through the 
pull down assays.   
 More effort is needed to elucidate protein-protein interactions of Symplekin within 
the mRNA processing machinery.  The assays must be optimized and have proper positive 
and negative controls working before any useful information will be gleaned from the 
experiments. This is one of Dr. Mindy Steiniger goals at this time; she has submitted a 
supplemental grant with Dr. William Marzluff to secure the future funding for this part of the 
project. 
 
5.4 Symplekin HEAT domain mutations for biochemical analysis 
 Anticipating the development of functional biochemical readout, many mutations 
were made in the Symplekin HEAT domain.  The most striking feature about the structure is 
the lengthy loop 8 that connects HEAT repeats 4 and 5.  To understand if this loop is 
important for protein binding, four different loop mutations were designed based on the 
characteristics of the native loop and characteristics of other loops in HEAT repeat units.  
Each of these mutations simultaneously removed residues alanine 191 through arginine 215, 
while adding in non-native residues, using one step site-directed mutagenesis reactions. First, 
a commonly used -G-S-G- loop was inserted between residues F190 and R216.  Second, a 
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single alanine was placed in this loop to see how restricted movement would affect function.  
Third, in an effort to keep a polar, uncharged residue resting above W152 and Y131, a -G-G-
Y-A- linker was inserted.  Finally, to keep a hydrophobic cap on these two residues, -G-S-F-
G- were added in place of loop 8 residues 191-215.  Each of these mutations has been made 
in the LIC MBP plasmid in Symplekin 19-271. 
 Deleting the whole loop is one approach to understanding the loop function, but we 
also wanted to see if the position of the loop over the concave surface seen in the crystal 
structure is important for function.  Thus, the anchoring residues (Figure 2.3) were mutated 
using site-directed mutagenesis.  In loop 8, aspartic acid 201, serine 203, proline 208, were 
all mutated separately to alanine.  Residues lysine 132 and arginine 258, on the concave 
surface of the protein, were also mutated because they are in polar contact with loop 8 to 
form a pocket between the loop and helices 3B, 4B and 5B.  The biochemical characteristics 
of aspartic acid 201 and arginine 258 mutations will be very interesting because their 
interaction was maintained throughout the wild-type molecular dynamics simulation (Figure 
4.9). 
 The above mutated DNAs were made and sequenced, but the proteins were not all 
expressed and purified.  The sequenced plasmids have a yellow sticker on the top of the 
eppindorf tube denoting the construct and mutant residue(s).  (Note: any eppendorf tube in 
my plasmid stocks with a sticker on the lid has been sequence verified in the region of the 
mutation.)  When a testable assay is developed by our collaborators, these mutations can be 
utilized to probe the function of loop 8 and the pocket formed by loop 8 and the concave 
helices 3-5B.  
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5.5 Figures and Tables 
Figures and tables are listed in the same order as they appear in the text of chapter 5. 
Figure 5.1 Symplekin HEAT domain structurally aligned with Pumilio bound to RNA 
Table 5.1 Nucleic acid substrates for Symplekin HEA domain binding assays  
Figure 5.2 Nucleic acid binding assays for Symplekin HEAT domain 
Table 5.2 List of proteins to be assayed for binding Symplekin  
Figure 5.3 TnT expression of CstF 64 and ssu72 on SDS-gel visualized by radiography 
Figure 5.4 Pull-down experiments with CstF64 and the Symplekin HEAT domain using 
amylose affinity resin 
 
Figure 5.5 Pull-down experiments with CPSF 73, CstF 64 and CstF64-hinge binding to full 
length Symplekin using GST affinity resin 
 
 
 
80 
 
NC
NC
5’
3’
 
Figure 5.1 Symplekin HEAT domain structurally aligned with Pumilio bound to RNA 
Pumilio (PDB: 1m8y), blue, uses its concave face to bind the bases of the RNA strand.  
Symplekin, red, has been structurally aligned to Pumilio using Dali74.   
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Table 5.1 Nucleic acid substrates for Symplekin HEAT domain binding assays 
5’‐fluorescein‐AAACCCAAA
U U
U C
C 
 G
  U
  C
  C
U
G
  C
  A
  G
  G
A
ACCCA 3’
SEQUENCE/STRUCTURE
Puf‐binding
NAME
Histone stem‐loop
5’‐fluorescein‐UUUA
A U
G
  G
G
C 
 A
  G
 
C 
  C
C
G
  U
  U
ACAAGGAGGU3’
G U
A
mmu‐let‐7d
15‐mer ss DNA 5’‐fluorescein‐ACAAGGAGGTCGTCA 3’
5’‐fluorescein‐CUUGUACAUA 3’
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Figure 5.2 Nucleic acid binding assays with Symplekin HEAT domain 
(A) Initial binding assay with 15-mer ssDNA and mmu-let-7d RNA.  (B) Binding assay with 
Symplekin HEAT domain and each of the four substrates.  No conclusion can be drawn from 
this work about Symplekin binding to DNA or RNA.  Further work must be done to elucidate 
this role for Symplekin.   
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Table 5.2 List of proteins to be assayed for binding Symplekin  
Name Fragment Fragment name Cloned into pENTR cloned into pEXP-2
272-419 structured region x
1-419 full length x x
108-214 hinge x x
215-419 C-term, ∆hinge x x
YPS 1-352 full length x
ssu72 1-195 full length x x
Symplekin 1-1165 full length x x
1-271 HEAT domain x x
1-756 full length x x
1-524 β-lactamase/β-casp
525-756 putative dimerization
1-684 full length x x
1-465 β-lactamase/β-casp
466-684 putative dimerization x x
HSF1 1-691 full length
CG8816 1-175 full length
CstF 64
CPSF100
CPSF73
 
84 
 
 
Figure 5.3 TnT expression of CstF 64 and ssu72 on SDS-gel visualized by radiography 
CstF64 C-terminus (215-419), full length (1-419), hinge region (108-214) and full length 
ssu72 were expressed through in vitro translation with 35S-radiolabeled amino acids to 
visualize the protein by radiography.  Positive and negative controls were run to ensure 
translation.  Positive control protein was Lsm11, while the negative control was empty 
vector.     
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Figure 5.4 Pull-down experiments with CstF64 and the Symplekin HEAT domain using 
amylose resin 
 
(A) CstF64 fragments assayed for binding with MBP (negative control) or MBP-Symplekin 
19-271.  “In” represents 10% of the total input.  (B) Full length CstF64 assayed for binding 
to MBP (negative control) or MBP-Symplekin.  Assay buffer conditions are listed as PBS or 
PBS +100, +200 or +300, indicating the amount of NaCl added to the PBS buffer. 
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Figure 5.5 Pull-down experiments with CPSF 73, CstF 64 and CstF64-hinge binding to 
full length Symplekin using GST affinity resin 
 
N-terminal GST tagged full length Symplekin or GST alone (negative control) assayed for 
binding with radio-labeled full length CPSF73, CstF64 or CstF-hinge region.  Three binding 
buffers were examined: PBS, PBS + 1M NaCl, and PBS + 0.1% CHAPS.  GST+ stands for 
GST-Symplekin.  As illustrated, binding was seen with GST alone, and therefore the results 
of GST-Symplekin binding are inconclusive. 
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Chapter 6: A novel fold in the TraI relaxase-helicase C-terminus 
is essential for conjugative DNA transfer 
 
6.1 Introduction to TraI and its role in conjugative DNA transfer  
 Conjugative DNA transfer (CDT) is one way that cells can transfer DNA from donor 
to recipient.  This process of horizontal gene transfer occurs between bacterial cells, plant 
cells and across these kingdoms94-97.  One of the main reasons that this area of study has been 
so prevalent is because CDT is a way to spread antibiotic resistance genes on mobile 
plasmids, thus creating new strains of drug-resistance microbes98,99.   In fact, the centers for 
disease control and prevention has made an action plan to address the escalating crisis of 
antibiotic resistant bacteria, and scientists in academic, industrial and government settings are 
fighting this growing epidemic.  To fight this problem, we must understand the mechanism 
and individual components of the bacterial conjugation.  CDT requires a close cell-cell 
junction through which the genetic material is transferred.  In the well-studied model F 
plasmid system in E. coli, CDT requires the type-IV secretion system (T4SS or TFSS) and a 
500 kD relaxosome.  The overall process is outlined in Figure 6.1.  A cell with the F plasmid 
(F+) assembles the type-IV secretion system to initiate cell contact with a recipient (F-) cell.  
Then, the relaxosome nicks and unwinds a single-strand of the F-plasmid and transfers the 
DNA to the recipient cell.  This yields a new F+ cell.   
 Figure 6.2 illustrates the proteins composing the relaxosome in the F-plasmid system.  
TraM, TraY and TraI are all encoded in the F-plasmid, while IHF (integration host factor) is 
encoded in the bacterial host genome.  These proteins have specific DNA binding sites on the 
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origin of transfer (oriT) in the F-plasmid100-103.  IHF bends the plasmid DNA104, which may 
bring TraY and TraM in closer contact with TraI.  TraY and TraM functions are not fully 
understood, however TraY and IHF must be present before TraI is able to bind to the oriT nic 
site105.  TraI is the main catalytic component of the relaxosome and functions to both nick 
and unwind the DNA for transfer106.   
 TraI is a multi-domain protein, consisting of an N-terminal relaxase, a central region 
of unknown function followed by a helicase domain and a C-terminal domain (Figure 6.3).  
The N-terminal relaxase contains highly conserved tyrosine residues and an HUH motif that 
are responsible for coordinating a transesterification reaction, cleaving the 5’ side of the 
DNA phosphate and creating a free 3’-hydroxyl; this domain binds site-specific ssDNA with 
a sub-nanomolar KD107.  Structures of this domain have been solved by the Redinbo and 
Schildbach groups108,109.  The helicase domain encompasses an ATPase domain, which is 
responsible for energetically driving the unwinding of the F-plasmid110.  While the detailed 
role of the C-terminus region is unknown, Matson et al. provide indirect evidence that 
indicates deletion of this region disrupts conjugative DNA transfer111.  It has also been 
speculated that the TraI C-terminus binds to TraM to stimulate the transesterification reaction 
in vivo112.   
 The Redinbo group has focused on understanding the structure and function of the 
TraI protein.  Scott Lujan solved the structure of the F-plasmid TraI relaxase domain and 
worked on designing inhibitors to this domain, to decrease plasmid transfer109.  Dr. Redinbo 
has started a company to commercially develop inhibitors of TraI to prevent spread of 
antibiotic resistance genes.  Two other graduate students are studying the relaxase domains in 
other plasmid systems and one student is investigating the F-plasmid TraI helicase domain.   
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Dr. Laura Guogas and I collaborated to structurally and functionally characterize the C-
terminal domain of F-plasmid TraI; the following sections describe the work we did to 
characterize this C-terminal domain.  Specifically, Dr. Guogas did the initial structure 
determination, and worked on the DNA binding assays and conjugation assays with Jin-Hyup 
Lee, while I completed the structure and utilized dynamic light scattering (DLS) to study the 
oligomeric state of the protein. Our paper, “A Novel Fold in the TraI Relaxase-Helicase C-
Terminal Domain is Essential for Conjugative DNA Transfer” was accepted to the Journal of 
Molecular Biology in December 2008113.   
 
6.2 Sequence conservation in the 1476-1629 TraI C-terminal region 
 TraI orthologs in related Yersinia pestis, Klebsiella pneumoniae, Salmonella typhi, 
Aeromonas salmonicida, Enterobacter sp. 638, Shigella sonnei, and the E. coli R-100 
conjugative plasmids were compared to the F plasmid TraI sequence using ClustalX114. A 
high degree of conservation (27-99% sequence identity) is maintained within the 1476-1629 
region ordered in our crystal structure.  In contrast, significant sequence divergence is 
observed in the far C-terminal region (1630-1756) (Figure 6.4).  Only the E. coli R-100 
resistance plasmid and a plasmid from S. sonnei maintain high sequence identity (96%) 
through the far C-terminus of their TraI proteins.  In contrast, the other plasmids exhibit only 
13-44% sequence identify within this region.  Thus, residues 1476-1629 in the TraI-CT 
comprise a conserved core domain present in TraI orthologs in a range of F-like conjugative 
plasmids. 
 
6.3 Solving the TraI C-terminal structure 
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 The gene encoding the TraI C-terminal domain (residues 1476-1756) was cloned into 
the vector pMCGS956 that fuses the expressed protein C-terminal to maltose binding protein 
(MBP) and a 6-His tag.  A TEV cleavage site is located between the target protein and the 
tags. One liter flasks of LB broth were inoculated at a ratio of 1:100 from a saturated 
overnight culture of BL21 cells containing this protein-expression plasmid.  Cells were 
grown at 37 °C under antibiotic selection with vigorous shaking until the cell density reached 
an OD600 of 0.6.  IPTG was then added to a final concentration of 0.5 mM and the 
temperature was dropped to 16 °C for overnight expression.  Cells were pelleted and 
resuspended in Nickel A buffer (20 mM Tris-HCl pH 7.4, 5% glycerol, 20 mM imidazole 
and 300 mM NaCl) at a ratio of 10 mL buffer/L of original culture.  Lysis was carried out 
using a sonicator (Heat Systems) pulsed on ice for approximately three minutes.  Following 
centrifugation at 27,000 g, the cleared lysate was loaded onto a gravity column packed with 
Nickel Sepharose 6 Fast Flow resin (Amersham) pre-equilibrated with Nickel A Buffer.  
Following washing to baseline, the His-tagged protein was eluted with a high imidazole 
Nickel B buffer (20 mM Tris-Hcl pH 7.4, 5% glycerol, 500 mM imidazole and 300 mM 
NaCl).  Fractions containing the TraI-CT MBP fusion protein (as evaluated by SDS-PAGE) 
were pooled and cleaved with 1% (w/w) TEV protease during dialysis into Nickel A buffer 
overnight at 4 °C.  Following cleavage, a second run through the nickel column separated 
TraI-CT from MBP; TraI-CT flowed through the column while the His-tagged MBP 
remained bound to the column and was later eluted with Nickel B buffer.  The purity of TraI-
CT was assessed by SDS gel electrophoresis.  Fractions containing clean TraI- CT were 
pooled for a final polishing step.  The protein was loaded onto a 26/60 Superdex 75 size 
exclusion column in 20 mM HEPES-KOH pH 7.4, 150 mM NaCl on an Akta Express FPLC 
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(GE Healthcare).  TraI-CT peak fractions were concentrated and buffer exchanged into 150 
mM ammonium acetate using an Amicon ultracentrifugation filter (Millipore).  TraI-CT was 
concentrated to 25 mg/ml as determined by UV280 nm measurement.   
 TraI-CT containing selenomethionine was generated using B834 cells, a methionine 
auxotroph cell line.  Cells were grown in selenomethionine specific media (Athena) 
supplemented with 50 mg/L selenomethionine.  Expression and purification were preformed 
as described above.   Additional proteins (TraM, TraI full length, TraI 1476-1630, and TraI 
1630-1756) were expressed and purified using the same protocol.   
 TraI-CT and selenomethionyl TraI-CT crystals were grown by hanging drop vapor 
diffusion at 25 °C.  Equal volumes of TraI-CT protein solution and well solution (1 M 
ammonium sulfate, 100 mM MES pH 6.0) were mixed, and crystals appeared in 7-10 days.  
Data were collected from a single crystal cryoprotected in 1.8 M lithium sulfate and flash 
cooled in liquid nitrogen.  A three wavelength MAD data set was collected at Sector 22-BM 
(SER-CAT) of the Advanced Photon Source, Argonne National Laboratory.  Data were 
indexed and scaled using HKL2000115 (Table 6.1, initial solution).   
 Dr. Guogas originally solved the structure in space group C2221 to 2.1 Å resolution. 
Data statistics for this solution are found in Table 6.1. However, after many rounds of 
refinement, the R factors remained above the acceptable level for 2.1 Å resolution (typically, 
R factors should be 10% of the resolution) and several other statistics were amiss: the 
completeness in the highest shell was only 60%, and the I/σ was less than 3.  Thus, Dr. 
Guogas thought perhaps the wrong space group was assigned, and so she performed 
molecular replacement with the model from the C2221 dataset and processed her original 
data into the space group P21.    However, this solution was still unsatisfactory. 
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 By completely reprocessing the data, I was able to discern the reason for the trapped 
R factors.   The data was originally extended to 2.1 Å, and the data in the shells between 2.4-
2.1 Å did not exhibit good quality statistics and therefore poor data had been incorporated 
into the structure solution.  Table 6.2 shows statistics for reflections in the highest 2 
resolution shells and total reflections from processing the MAD dataset in the C2221 space 
group.  The overall average redundancy and completeness are higher in the data that has been 
cut back to 2.4 Å.  For example, the highest resolution shell of the 2.10 Å data has only 
63.6% completeness. The highest resolution shell in the 2.4 Å data has 89.4% completeness, 
a value equivalent to the overall completeness for all reflections in the 2.10 Å data (89.3%).  
The overall completeness for the data cut back to 2.4 Å has a much more acceptable value of 
97.5%.   Considering the intensity and error in the data, the two highest resolution shells for 
the 2.1 Å data have 53.1% and 57.2%  of reflections with an I/σ value <2, respectively (I is 
intensity and σ is the error in the intensity).  In other words, more than half of the reflections 
in the highest resolution shells have intensities that are only 2x greater than the error.  
Trimming reflections to 2.4 Å reduced I/σ in the highest shell to 46.8%.  Including all 
reflections, I/σ is < 2 in 31.1% of the 2.1 Å data, but only 23.4% in the 2.4 Å data.  Thus, the 
highest accepted resolution for the final structure is 2.4 Å and I resolved the structure with 
the new resolution limit. 
 Four of ten possible selenium atoms in the two molecules in the asymmetric unit (five 
methionines per monomer) were located by the program SHARP116 and used to build an 
initial model. Two methionine residues (1479, 1588) per monomer were located in the 
ordered 1476-1629 region of the structure, while the remaining three methionines (1672, 
1739, and 1743) per monomer were located in the missing 1630-1756 region. The electron 
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density map was improved by a combination of solvent flipping using the program 
SOLOMON117 and density modification using DM118, both operating under SHARP. 
Automatic model building using ARP/wARP placed approximately 100 alanine residues in 
each monomer.  The remaining residues and side chains were placed manually using the 
program Coot119.  Model refinement was conducted using the maximum likelihood method in 
REFMAC 5.2120, CNS121, and the free R-factor  (with 5% of the data set aside for free R).  
The final R/Rfree factors of 0.22/0.26 were reached after several rounds of refinement (Table  
6.3). The final asymmetric unit contains two protein monomers forming a dimer, along with 
130 water molecules and 10 sulfate ions. The C-terminal residues 1630-1756 of the protein 
construct were missing in each protein monomer and are not present in the final refined 
model.   
 The experimental maps produced following phasing and solvent flattening (Figure 
6.5) allowed the building of a dimer of residues 1476-1629, approximately two-thirds, of the 
TraI-CT in the asymmetric unit.  Residues in the far C-terminus (1630-1756) could not be 
placed in the model. The Matthew’s parameter (VM) for two molecules of the 1476-1629 
region in the asymmetric unit was 2.8; in contrast, two molecules of the complete TraI C-
terminal domain (residues 1476-1756) would exhibit a VM of 1.5.  Thus, it is unlikely that the 
far C-terminal region is present in the crystal. Indeed, SDS-PAGE of washed and dissolved 
crystal specimen supports this conclusion (data not shown).  It is possible that a peptide 
cleavage event occurred between amino acids Asn-1631 and Ser-1632, a dipeptide known to 
be susceptible to succinimide-based degradation122,123.    
  
6.4 The C-terminal domain of TraI exhibits a novel fold  
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 The structured 1476-1629 region of the TraI-CT is composed of an α-Domain 
containing two α-helices at the N-terminus, a proline-rich loop, and a compact α/β-Domain at 
the C-terminus (Figure 6.6).  The α/β-Domain contains two three-stranded β-sheets, a small 
β-hairpin loop and two helices. Antiparallel β-sheet 1 (β-strands 1-3) contains a β-hairpin 
loop inserted between β-strands 2 and 3.  In β-sheet 2, β-strands 4 and 5 are antiparallel, 
while the insertion of α-helix 3 allows β-strand 6 to run parallel to β-strand 5.   
 TraI-CT crystallized as a domain-swapped dimer in the asymmetric unit.   The N-
terminal α-Domain of one monomer docks into the core domain of the second monomer 
(Figure 6.7A). β-sheet 1 forms a binding surface for helix 1 of the second monomer in the 
asymmetric unit, while the second β-sheet (β-strands 4-6) packs against helix 3.  The α- and 
α/β-Domains are connected by a proline-rich loop, which is rigid relative to the remainder of 
the protein.  The mean thermal displacement parameter (B-factor) for all protein atoms is 
36.0 Å2 (Table 6.1), while prolines 1523, 1525 and 1530 in this loop exhibit B-factors of 
26.1, 25.8 and 26.1 Å2, respectively.  A crystallographic 2-fold axis of symmetry in the 
C2221 space group further generates an intimately associated tetramer formed by two 
domain-swapped dimers (Figure 6.7B).   
 Two potential conformations of 1476-1629 region of the TraI-CT monomer can be 
hypothesized: an extended arrangement, in which one monomer is simply removed from the 
dimer (Figure 6.7C; see also Fig. 6.6), and an α + α/β globular arrangement, in which a 
single domain is generated by pairing the α -Domain of one monomer with the α/β-Domain 
of its domain-swapping partner (Figure 6.7D).  Both the extended and the globular 
conformations were examined in DALI searches of the Protein Data Bank124 for structurally-
similar folds.  Significant homology to TraI-CT was not detected in protein structure 
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similarity searches.  Using DALI, two hits were observed for the extended form of TraI-CT, 
and three for the globular form.  For both the extended and the globular conformations, the 
best match (with a DALI Z-score of 2.5 and 3.1 respectively) was a portion of Pseudomonas 
putida 2-oxoisovalerate dehydrogenase (PDB ID 1qs0).  While this molecule contains a 
similar degree of α and β character, we discerned no structural similarity with the TraI-CT.  
Indeed, up to eleven separate regions of structural similarity between the TraI-CT and the 
oxidoreductase were observed; the aligned segments were 3 to 13 residues in length with 
root-mean-square deviations of 2.8 to 3.9 Å between Cα positions. After the oxidoreductase, 
the next best DALI matches had Z-scores of 2.2 and 1.7.  Using secondary structure 
matching server (SSM)125 and either the extended or globular forms of TraI-CT as a search 
model produced only three hits, all of which exhibited insignificant statistical values.  These 
observations suggest that the 1476-1629 region of the F TraI C-terminal domain exhibits a 
novel fold. 
 
6.5 DLS confirms the monomeric C-terminal structure 
 To investigate the polydispersity and oligomerization state of TraI constructs, 
dynamic light scattering experiments were employed using a Wyatt DAWN EOS light 
scattering instrument interfaced to an Amersham Biosciences Akta FPLC with Superdex 
S200 size exclusion column, a Wyatt Optilab refractometer, and Wyatt dynamic light 
scattering module. Constructs of TraI residues1476-1630 and 1476-1756 were expressed and 
purified using the protocol outlined in section 6.4.  The samples were dialyzed into dynamic 
light scattering (DLS) buffer (10 mM potassium phosphate pH 7.1 and 150 mM NaCl). Data 
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were analyzed using the ASTRA software from Wyatt Technology. Molecular weights were 
calculated using the following equation:  
cA
MPR
cK
22
)(
1
)(
* +Θ=Θ   Equation 6.1 
where K* is an optical parameter, c is the sample concentration, M is molecular weight, R(Θ) 
is the excess intensity of scattered light at DAWN angle Θ, P(Θ) is a function describing the 
angular dependence on scattered light, and A2 is the second virial coefficient. 
 Both the complete C-terminus (1476-1756) and a construct containing the ordered 
region of the crystal structure (1476-1630) eluted as single peaks on the Superdex 200 
column.  Coupling size exclusion chromatography with dynamic light scattering (SEC-DLS) 
and refractometry facilitated the calculation of sample molecular weights. Both C-terminal 
constructs (1476-1756, 1476-1630) exist as homogeneous monomers with less than 3.5% 
difference between calculated and theoretical molecular weights (Table 6.4). It was noted 
that the theoretical molecular weight for the structured region of the TraI-CT (1476-1630), 
16.7 kD, was smaller than the measured molecular weights from the SEC-DLS experiment 
(17.1–17.6 kD; Table 6.4). This observation suggests that the TraI-CT monomer may be in 
equilibrium between the extended and globular states (see Figures 6.7C and 6.7D, 
respectively). Limited proteolysis using either trypsin or chymotrypsin generated a 3 kD 
product from the TraI-CT (data not shown). We hypothesize that this 3 kD fragment is the 
28-residue α-domain, which is connected to the TraI-CT α/β-domain by the proline-rich loop 
composed of a sequence susceptible to cleavage by trypsin and chymotrypsin.  This result 
further supports the conclusion that the TraI-CT monomer may shift between the closed and 
open states, the latter of which providing a substrate more amenable to proteolysis.  The “far” 
C-terminal region (1630-1756), which was not present in our crystal structure, eluted in the 
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void volume (MW > 600 kDa) but does not precipitate in the standard aqueous buffers 
employed (data not shown), suggesting a soluble aggregate. 
 
6.6 Transfer activity of TraI C-terminus truncation mutants and examination of 
specific structural features 
 DNA transfer assays were conducted to test the importance of distinct regions of the 
F TraI C-terminus in conjugation (full methods and materials can be found in primary 
citation113).   A panel of C-terminal truncation mutants was generated by introducing a stop 
codon at positions 1504, 1524, 1550, 1600, 1630, 1680, or 1720.  DNA transfer efficiency 
(the number of transconjugation events per donor cell) was evaluated and normalized to 
wild-type levels (Figure 6.8). Previous work establishes that TraI is essential for CDT; when 
a plasmid with no TraI gene (∆TraI) is utilized as a control, no conjugation is detected20,23.  
Deletion of residues 1504-1756 or 1524-1756 resulted in a complete loss of conjugative 
transfer (Figure 6.8 A).  Elimination of residues C-terminal to positions 1550, 1600 or 1720 
resulted in a 100-fold decrease in the transfer efficiency, while removal of residues C-
terminal to 1630 or 1680 resulted in a 1,000-fold reduction in transfer efficiency.  Full 
activity is observed only with the complete protein; removal of just 36 residues reduces 
conjugative DNA transfer (CDT) by more than 100-fold (N1720 column in Figure 6.8A).   
  The importance of specific TraI-CT structural features was next examined using 
conjugative DNA transfer assays.  First, three prolines (1518, 1523 and 1525) within the 
proline-rich loop were mutated simultaneously to glycine (Figure 6.9 A, B).  Prolines 1523 
and 1525 are completely conserved, and proline 1518 is highly conserved in related TraI 
protein sequences (see Figure 6.4).  Together, they may impart rigidity to the 1517-1525 
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loop (see above for B-factor analysis).  Mutation of the three prolines dropped CDT 100,000-
fold (Figure 6.9A).  Second, residues 1517-1525, the entire proline-rich loop, were deleted. 
Elimination of the 1517-1525 loop reduced CDT 10,000-fold (Figure 6.9A).  Thus, the 
conformationally-restricted proline residues within this loop are essential for CDT.  
 Third, the importance of contacts between α1 and β-sheet 1 (h1/s1) was examined 
(Figure 6.9C).  Mutation of residues V1478, E1482 and F1485 to alanine on α1, coupled 
with mutation of G1540 to glutamic acid and I1541 to alanine on β2 (h1/s1), resulted in only 
a 10-fold decrease in transfer efficiency relative to wild type TraI (Figure 6.9A).    These 
mutations were designed to disrupt the interaction between α1 and β-sheet 2.  Although we 
did not establish that this interaction was successfully disrupted (by measuring changes in 
protein stability, for example), the relatively moderate 10-fold decrease in transfer efficiency 
lead us to conclude that the α1/β-sheet 1 interaction is not essential to CDT. 
 Fourth, contacts between α3 and β-strands 4 and 6 of β-sheet 2 (h3/s2) were 
examined.  In contrast to the α1/β-sheet 1 interaction, the mutation of residues L1574, Q1575 
and V1603 (Figure 6.9D) simultaneously to alanine resulted in a >200-fold decrease in 
transfer efficiency (Figure 6.9A).   Mutation of L1574 and V1603 to alanine is expected to 
disrupt the hydrophobic interactions between helix 3 and sheet 2.  The Q1575 side chain 
nitrogen on β-strand 4 forms polar contacts with two main-chain oxygen atoms in the loop 
that packs helix 3 against β-strand 6, and also forms a polar contact with one main-chain 
oxygen on helix 3. When alanine replaces Q1575, these polar contacts would be eliminated.  
Thus, the globular nature of the α/β-domain of the TraI C-terminus plays an important role in 
conjugative DNA transfer.  Taken together, these data functionally annotate the crystal 
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structure of the TraI C-terminal domain, and they establish that the α/β-domain and the rigid 
1517-1525 loop are important for conjugative DNA transfer. 
 
6.7 TraI C-terminal domain binds ssDNA  
 Because TraI contains domains that perform site-specific DNA nicking and highly 
processive DNA unwinding activities, the ability of constructs of the TraI C-terminal domain 
to bind to DNA was examined using fluorescence anisotropy.  (Full materials and methods 
can be found in the corresponding publication113.  The full TraI C-terminal domain (1476-
1756) did not bind to a double stranded stretch of DNA (data not shown), in accordance with 
previously published data112. The C-terminal domain binds to a 34 nucleotide single-stranded 
DNA (ssDNA) oligo with Kds of 2.9 µM and 7.7 µM in 75 mM and 150 mM NaCl, 
respectively (Figure 6.10, blue). A protein construct containing only the far C-terminal 
residues (1630-1756) formed a soluble aggregate in solution and was therefore not suitable 
for anisotropy studies.  Similarly, the 1476-1629 fragment without the far C-terminal 
residues aggregated at 75 mM NaCl.  At 150 mM NaCl, the 1476-1629 fragment exhibited 
poor binding to ssDNA (Kd>22.6 µM) (Figure 6.10, black).  (A Kd value greater than 22.6 
µM indicates a dissociation constant higher than the highest protein concentration tested.)   
 The proline loop deletion (∆loop) and Pro-to-Gly mutant (pmut) forms of the TraI C-
terminal domain (1476-1756) were also examined.   The ∆loop form of TraI 1476-1756 binds 
ssDNA poorly, with Kds of >17.1 µM and >15.9 µM at 75 mM and 150 mM NaCl, 
respectively (Figure 6.10, red).  Similarly, mutating prolines 1518, 1523 and 1525 to glycine 
within this loop region also produced a form of TraI 1476-1756 that binds ssDNA poorly, 
with Kds of >13.9 µM and >18.2 µM at 75 mM and 150 mM NaCl, respectively (Figure 
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6.10, green).  As a negative control, we found that bovine serum albumin did not bind to 
ssDNA at either 75 mM or 150 mM NaCl (data not shown).  These results demonstrate that 
the TraI C-terminal domain binds ssDNA, and indicate that both the 1517-1525 loop and the 
1630-1756 region are essential for this activity.  Thus, the presence and the relative structural 
rigidity of the 1517-1525 loop are required for ssDNA binding. 
 
6.8 Figures and Tables 
Figures and tables are listed in the same order as they appear in the text of chapter 6.  Figures 
taken directly from our publication have the citation in the figure title113.   
Figure 6.1 Simple model of conjugative DNA transfer in the F-plasmid system 
Figure 6.2 Schematic of the F-plasmid relaxosome 
Figure 6.3 Domain structure of TraI 
Figure 6.4 Sequence alignment of E. coli F-plasmid TraI C-terminus with TraI orthologs 
Table 6.1 Original statistics for the TraI C-terminal structure 
Table 6.2  Redundancy, I/σ  and completeness for data scaled to 2.1 Å or 2.4 Å resolution 
Table 6.3 Final data collection, phasing, and refinement statistics 
Figure 6.5 Two portions of the final model with the experimental electron density from MAD 
phasing 
 
Figure 6.6 TraI C-terminal structure 
Figure 6.7  Dimer, tetramer and monomer representations of the TraI C-terminal structure 
Table 6.4. Size exclusion chromatography and dynamic light scattering 
Figure 6.8 Transfer efficiency of TraI C-terminus deletion mutants 
Figure 6.9 Plasmid transfer efficiency using specifically designed mutant TraI proteins to 
examine contacts within the C-terminal structure 
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Figure 6.10 Binding of ssDNA by the TraI C-terminus measured by fluorescence anisotropy 
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F+ F‐
F+ F‐
F+ F‐
F+ F+
 
Figure 6.1 Simple model of conjugative DNA transfer used in the F plasmid system 
An F+ cell (brown) contacts an F- cell (blue) through the type four secretion system (TFSS) 
(less than symbol).  The relaxosome (not shown) assembles on the F plasmid (red circle) and 
nicks the DNA, unwinds the DNA and couples with the TFSS to transfer the strand to the F- 
cell.  The DNA is then replicated and an intact F-plasmid is now present in the new cell 
making it an F+ cell. 
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Figure 6.2 Schematic of the F-plasmid relaxosome113 
The F plasmid-encoded proteins TraM (green), TraY (orange), TraI (blue) and the E. coli 
host encoded integration host factor (purple) bind the F plasmid DNA in a site- and 
sequence-specific manner.  The nucleotides most proximal sites to the nic site (IHFA, SbyA, 
and SbmC) bound by each protein are indicated by color and numbered relative to the origin 
of transfer nic site (oriT nic). The region of ssDNA to be transferred to the recipient bacterial 
cell via a type IV secretion system (Type 4 SS) is shown.   
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1756309 990 1476
Relaxase
1
C‐Term
F‐Plasmid TraI
HelicaseUnknown function  
Figure 6.3 Domain structure of TraI113 
The numbers represent amino acid positions.  The N-terminal 300 residues compose the 
relaxase domain, while residues 990-1476 compose the helicase domain.  The yellow bars 
represent canonical helical motifs.  The 309-990 region has an unknown function and the 
1476-1756 region makes up the C-terminal domain. 
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proline
loop
α1
α3
β1 β2
β3 α4
α2 hairpin
β6β4 β5
E. coli-F      ITEREAALPEGVLREPQRVREAVREIARENLLQ-ERLQQMERDMVRDLQKEKTLGGD--------
E. coli-R100   ITEREAALPESVLRESQREQEAVREVARENLLQ-ERLQQIERDMVRDLQKEKTLGGD--------
Shigella       ITEREAALPESVLRESQREREAVREVARENLLQ-ERLQQMERDMVRDLQKEKTPGGD--------
Yersinia       PASPLTLPDAPEER---RRDEAVSQVVRESVQR-DRLQQMERETVRDLEREKTLGGD--------
Klebsiella     -TEKTTLPDDPQFR---RQEEAIQQVASERLQR-ERLQAVERDMVRDLNREKTLGGD--------
Salmonella     GTERETRELDEAVREAVAEGREPRQQVRDQMQR-TEREWVVNVPEKEIELEKTLGGD--------
Aeromonas      QLNKDAELSERQLRKLAEIRDVAKAKFTHELHD--KLDKLEREIIKELTKGE-------------
Enterobacter   AARRHSEKAEIVQDRTPEERAGASRVVSELANSERDIVRQPEPAERGRMPERDEQTLTHTIQKER
Identical
Very Similar
Similar
1476 1515 1555
E. coli-F      REVMNAERLFSTARELRDVAAGRAVLRQAGLAGGDSPARFIAPGRKYPQPYVALPAFDRNGKSAGIWLNPLTTDDGNGLR 
E. coli-R100   REVMNAQRLFSTARELRDVAAGRAVLRQAGLAGGDSPARFIAPGRKYPQPYVALPAFDRNGKSAGIWLNPLTTDDGNGLR 
Shigella       REVMNAERLFSTARELRDVAAGRAVLRQAGLAGGDSPARFIAPGRKYPQPYVALPAFDRNGKSAGIWLNPLTTDDGNGLR 
Yersinia       RAVANAARLTATAKALGEVPAGRAALRQAGLQPEGSMAKFISPGRKYPQPHVALPAFDRNGRQAGVWLSALTSGDGQ-LK 
Klebsiella     RAVKTADLLFGRARPLDETAAGRAALQQSGLAQGSSPGKFISPGKKYPQPHVALPAFDKNGKAAGIWLSPLTDRDGR-LE 
Salmonella     HESDTGNRLLATASRLDKTALGRRVLAENGLEG-ETMARFIAAGKKYPSPYVALPAWTRHGKAAGALLTEIRIEDDGMRV 
Aeromonas      KGLKVADMLLGAASPMRSTALGRHVLKTHQLDEQQHMGKYIAPGKKYPTPHAAFPVWDNNGKPAGAAMVELQSHHQNKGP 
Enterobacter   RQ--QARAIWAMGQPVSKTAIGRAWVRHQGMQDTSLTAKIIPATRRFPEPALALPVYDNNGKSAGLALVSLVS--SPEGR
E. coli-F      GD-IPDNSVQPGAGNGEPVTAEVLAQRQAEEAI-RRETERRADEIVRKMA--ENKPDLPDGKTEQAVREIA-GQERDRAA 
E. coli-R100   GD-IPDSSVQPGAGNGEPVTAEVLAQRQAEEAI-RRETERRADEIVRKMA--ENKPDLPDGKTEQAVREIA-GQERDRAD 
Shigella       GD-IPDNSVQPGAGNGEPVTAEVLAQRQAEEAI-RRETERRADEIVRKMA--ENKPDLPDGKTELAVREIA-GQERDRAA 
Yersinia       ADGLPDG---TGTQPAETVPPEVLAQQALEAEV-QRELDKRAEEAVREMA---RSGDRPAGGADVAVRDVVRDMDRIKET 
Klebsiella     AE-PAPVAPVPQAGADIILPPEVLAQRAAEEQQ-RREMEKKAEQTAREMAGEARKAGEPADRVKEVIGDVIRGLERDRPG 
Salmonella     EPDEVERTVRSVAEAESAAKAEDPITLPPDEQQKLAEAQEKAAQELAEQARQDLLPALPGTEGDKPDPLLSASDERRLRD 
Aeromonas      VSDTDAQHLQKESERELPLPQDMTTKEAKRQDEMIKTVAREKEQPDIKLP--DDKQQAVNRDDKRLHNDIH---------
Enterobacter   VSRRETDIVLPETEKQKPEQAMSADTEKAREQEALRRIAEETLQIKPEFTG-TEASQESNEPDRSTLKNIASSEDIAASD
E. coli-F      GFSGEGRVKGSGDAQFVALQGSRNGESLLADNMQDGVRIARDNPDSGVVVRIAGEGRPWNPGAITGG--- ------RVW 
E. coli-R100   GFSGEGRVKGSGDAQFVALQGSRNGESLLADNMQDGVRIARDNPDSGVVVRIAGEGRPWNPGAITGG--- ------RVW 
Shigella       GFSGEGRVKGSGDAQFVALQGSRNGESLLADNMQDGVRIARDNPDSGVVVSIAGEGRPWNPGAITDG--- ------RVW 
Yersinia       GLAGEGRVMGSGDAAFAGLQASRNGESLLARDMEEGVRLARENPQSGVVVRLEGEVRPWNPGAITGG--- ------RVW 
Klebsiella     AIGGEGRIMGNEDARFVALQNSRNGESLLAGNMGEGVRMARDNPDTGVVVRLAGDDRPWNPGAMTGG--- ------RVW 
Salmonella     VLSDESRLRGGEDAQFAGLQASRNGQTLIADDAQTALRLAQENPESGVVIRLHGEERLLNAARLTGG--- ------RIT 
Aeromonas      TLDSEYRLVANERAEFIGLQRASNGETRIATSLEDGIAMATKHPHSGILVSINGAPPPFNVNRMTGG--- ------KLV 
Enterobacter   LTQGDTRMVMTERARGAVLQRSQSGHTHVVSDLGAALEAVKANPKDGVVWQTGEESPSSHLIKVTGGERQ DAEERAAIN
16251587
1700
1756
 
Figure 6.4 Sequence alignment of E. coli F-plasmid TraI C-terminus with TraI 
orthologs  
 
Sequence alignment showing similar (blue), highly similar (yellow) and identical (red) 
residues.  The sequence of the E. coli F plasmid TraI is compared to TraI orthologs from the 
E. coli plasmid R-100, as well as plasmids from S. sonnei (Ss046), Y. pestis (MT), K. 
pneumoniae (pMGH78587), S. typhi (pED208), A. salmonicida A449 (p5), and Enterobacter 
sp.638.  The positions of deletion-generating stop codons described in Figure 5 are indicated 
with red triangles, and the positions of mutations described in Figure 6 are indicated with 
black triangles. 
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Table 6.1 Original statistics for the TraI C-terminal structure 
aSpace group assignment changed during the course of refinement; see Experimental Procedures.  
bRsym=Σ|I‐Imean|/ΣI where I is the observed intensity and Imean is the average intensity of several symmetry 
related observations. 
cRwork=Σ|Fo‐Fc|/ΣFo where Fo and Fc are the observed and calculated structure factors, respectively. 
dRfree=calculated as above for 5% of data not used in any step of refinement. 
Data collection  
X‐ray source APS SER‐CAT BM‐22 
Space group  C2221  P21 
Unit Cella 
    a, b, c (Å); α, β, γ (°) 
40.8, 139.8, 126.8;
90,90,90 
40.8,126.5,72.8;
90,106.2,90 
 Peak Inflection Remote Peak 
Wavelength ( Å) 0.97835 0.97873 0.97126 0.97835 
Resolution (Å) (highest shell) 50.0‐2.10 
(2.18‐2.10) 
50.0‐2.40 
(2.48‐2.40) 
50.0‐2.50 (2.59‐
2.50) 
50.0‐2.10 
(2.18‐2.10) 
Rsym
b 8.2 (28.6) 9.6 (42.5) 9.6 (41.9) 9.2 (37.7) 
I /σI 17.4 (2.8) 22.9 (3.7) 13.9 (2.3) 14 (2.6) 
Completeness (%) 87.6 (60.5) 98.8 (92.9) 96.6 (81.3) 95.3 (80.4) 
Redundancy 3.5 (2.9) 3.7 (3.2) 6.8 (6.0) 3.7 (3.3)    
Phasing     
Mean Figure of Merit      
    Sharp‐Centric 0.301    
    Sharp‐Acentric 0.184    
    Solomon & DM 0.804    
Refinement     
Resolution (Å) 50‐2.10    
No. reflections 39344    
Rwork
c  0.247    
Rfree
d 0.283    
Molecules per asymmetric unit (AU)a 4    
No. of amino acids/AU 614    
No. of waters/AU 393    
No. of  Ammonium sulfates/AU 6    
B‐factors     
    Protein 37.4    
    Ammonium Sulfate 82.0    
    Water 42.4    
R.m.s deviations     
    Bond lengths (Å) 0.007    
    Bond angles (°) 1.33    
Ramachandran (%)     
Favored, allowed, disallowed 95.31, 3.56, 0.83  
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Table 6.2  Redundancy, I/σ  and completeness for data scaled to 2.1 Å or 2.4 Å 
resolution 
Statistic Shell (Å) Value Shell (Å) Value
Average redundancy per shell 2.26‐2.18 5.6 2.59‐2.49 6.3
2.18‐2.10 5.2 2.49‐2.40 6.1
All 6.6 All 6.9
Percent of total observed  2.26‐2.18 53.1 2.59‐2.49 45.8
reflections with  2.18‐2.10 57.2 2.49‐2.40 46.8
I/σ  of <2  All 31.1 All 23.4
Percent of total observed  2.26‐2.18 87.0 2.59‐2.49 78.3
reflections with  2.18‐2.10 89.5 2.49‐2.40 81.7
I/σ  of <10 All 59.8 All 50.4
% Completeness 2.26‐2.18 71.6 2.59‐2.49 91.5
(% reflections observed) 2.18‐2.10 63.6 2.49‐2.40 89.4
All 89.3 All 97.5
C2221 scaled to 2.1 Å C2221 scaled to 2.4 Å
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Table 6.3 Final data collection, phasing, and refinement statistics113 
Data collection      
X-ray source APS SER-CAT BM-22 
Space Group C2221 
Unit cell: a,b,c (Å); α, β, γ (°) 40.8, 139.8, 126.5; 90, 90, 90 
   Peak Inflection Remote 
Wavelength (Å) 0.97835 0.97873 0.97126 
Resolution (Å) (highest shell) 50.0-2.39 
(2.49-2.39) 
50.0-2.40 
(2.49-2.40) 
50.0-2.50 
(2.59-2.50) 
Rsym 8.8 (27.6) 9.6 (42.5) 9.6 (41.9) 
I/σ 28.6 (5.4) 22.9 (3.7) 13.9 (2.3) 
Completeness (%) 97.5 (89.4) 98.8 (92.9) 96.6 (81.3) 
Redundancy 6.9 (6.10) 3.7 (3.2) 6.8 (6.0) 
Phasing     
Mean Figure of Merit     
Sharp-Centric 0.301    
Sharp-Acentric 0.184    
Solomon & DM 0.804    
Refinement     
Resolution (Å) 50.0-2.4    
No. reflections 24509    
Rwork  0.220    
Rfree 0.263    
Molecules per asymmetric unit 
(AU) 2    
No. of amino acids per AU 307    
No. of waters per AU 130    
No. of sulfates per AU 10    
B-factors      
Protein 36.0    
Sulfates 90.6    
Water 38.1    
R.M.S. deviations      
Bond lengths (Å) 0.008    
Bond angles (°) 1.4    
Ramachandran (%)      
Favored 96.4    
Outliers 0    
Rsym=Σ|I‐Imean|/ΣI where I is the observed intensity and Imean is the average intensity of several symmetry related 
observations. 
Rwork=Σ|Fo‐Fc|/ΣFo where Fo and Fc are the observed and calculated structure factors, respectively. 
Rfree=calculated as above for 5% of data not used in any step of refinement. 
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Figure 6.5 Two portions of the final model with the experimental electron density from 
MAD phasing113 
 
Stereoview of two portions of the original 2.4 Å resolution solvent-flattened experimental 
electron density map after SHARP, SOLOMON and DM (contoured at 1.5 σ with the final 
refined protein model.  Residues isoleucine 1541 through threonine 1548 are illustrated in 
(A), while (B) shows the proline rich loop between residues alanine 1517 and proline 1525. 
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Figure 6.6 TraI C-terminal structure113 
Crystal structure of a monomer of the F plasmid TraI-CT.  Secondary structure elements are indicated 
in green (helices), blue (β‐strands), grey (loops) and red (proline-rich loop). 
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Figure 6.7  Dimer, tetramer and monomer representations of the TraI C-terminal 
structure113 
 
(A) TraI-CT forms a domain-swapped dimer in the asymmetric unit.  Each monomer is 
oriented with the N-terminus (α-Domain) of one monomer contacting the C-terminus (α/β-
Domain) of the other monomer. (B) A domain-swapped tetramer is also generated between 
symmetry-related dimers. Each monomer is oriented with the N-terminus towards the core of 
the tetramer and the C-terminus at the edge (orange interacts with blue, and purple with 
yellow). Two monomeric forms of the TraI C-terminus can be modeled: extended (C) and 
globular (D).  
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Table 6.4 Size exclusion chromatography and dynamic light scattering113 
 
Protein Construct TraI 1476-1756 TraI 1476-1630 
Theoretical MW (kDa) 31.180 16.690 
Molar Mass Moments (kDa)     
Mn (% error) 32.31 (0.11%) 17.08 (0.5%) 
Mw (% error) 32.32 (0.11%) 17.35 (0.5%) 
Mz (% error) 32.33 (0.25%) 17.61 (0.5%) 
Polydispersity     
Mw/Mn (% error) 1.000 (0.2%) 1.016 (0.7%) 
Mz/Mn (% error) 1.001 (0.3%) 1.041 (91.1%) 
 
*Weight average molar mass defined as Mw=Σ(ci·Mi)/ Σci, Number average molar mass defined as  
Mn= Σci / Σ(ci/Mi),  Z-average molar mass defined as Mz = Σ(ci·Mi)2/ Σ(ci·Mi).   
Polydispersity of the sample equals one only when the sample has homogenous molecular mass (i.e. 
one oligomeric state and independent of averaging method).   
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Figure 6.8 Transfer efficiency of TraI C-terminus deletion mutants113 
 
(A)  Conjugative DNA transfer efficiencies of TraI deletion mutants.  Constructs include 
residues N-terminal to the indicated residue; for example, N1550 includes residues 1-1550.  
(B) The TraI-CT structure annotated with the stop codon sites used for this truncation 
analysis. 
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Figure 6.9 Plasmid transfer efficiency using specifically designed mutant TraI proteins 
to examine contacts within the C-terminal structure113 
 
(A) Conjugative DNA transfer efficiencies of bacterial strains containing specifically 
designed TraI-CT mutations. (B) “Pmuts” indicates the mutation of prolines 1518, 1523 and 
1525 simultaneously to glycine, while “∆loop” indicates the removal of the entire proline-
rich loop. (C) The helix 1/sheet1 (h1/s1) variant is the mutation of V1478, E1482 and F1485 
all to alanine on helix 1 and the mutation of I1541 to alanine and G1540 to glutamic acid on 
strand 2. (Helix 1 is shown here in orange to indicate the domain swapped interaction.)  (D) 
The helix 3/sheet2 (h3/s2) mutants replace L1574, Q1575 and V1603 all with alanine. 
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Figure 6.10 Binding of ssDNA by the TraI C-terminus measured by fluorescence 
anisotropy113 
 
TraI 1476-1756 at 75 and 150 mM NaCl is indicated by solid and dashed blue lines (Kd =2.9 
µM and Kd =7.7 µM) respectively.  TraI 1476-1756 with a deletion of the proline rich loop at 
75 and 150 mM NaCl is indicated by solid and dashed red lines (Kd >17.1 µM and Kd >15.9 
µM) respectively.  TraI 1476-1756 with mutations of prolines 1518, 1523 and 1525 to 
glycine at 75 and 150 mM NaCl is indicated by solid and dashed green lines (Kd >13.9 µM 
and Kd >18.2 µM) respectively, while the binding of 1476-1630 at 150 mM NaCl is indicated 
in black (Kd >22.6µM). 
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Chapter 7: Other (unpublished) projects 
 
7.1 Initial characterization of TraI putative GTPase 
 Investigation of the E. coli F-plasmid TraI protein has been a central focus for the 
Redinbo laboratory since 2004, when Scott Lujan started collaborating with Dr. Matson in 
the UNC-CH Biology Department.  Scott crystallized the N-terminal relaxase domain of TraI 
and demonstrated its role in bacterial conjugative DNA transfer through inhibiting plasmid 
tranfer109.   Chapter 6 introduces this protein and discusses the structure and function of the 
C-terminal portion of TraI113.  The central region of the protein had not yet been assigned any 
functional role, but we identified a putative GTPase in the central region of TraI, 
encompassing residues 309-590.  I started working on this part of the protein as a training 
project with my second undergraduate student, Sung Taek Kim. The project goal was to 
determine if this central region is in fact an enzyme with GTPase activity and to determine 
which residues are the most important for GTP binding. The following sections discuss our 
preliminary work. 
7.1.1 Primary sequence analysis of TraI’s putative GTPase 
 Examination of the primary sequence of TraI reveals amino acid sequences that are 
found in typical GTPases, including a Walker A box, Walker B box, and a nucleotide-
specific box126,127.  Table 7.1 lists the canonical residues for each motif and the residues 
found in TraI. The lowercase x represents any amino acid and lowercase h denotes a 
hydrophobic residue.  The Walker A box is responsible for binding the γ-phosphate of the 
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NTP, while the Walker B motif is used for coordinating the metal ion used in the cleavage 
reaction126-128.  The nucleotide-specific box is responsible for coordinating the specific 
nitrogenous base.  TraI has a nucleotide-specific box that reflects a GTP binding motif, not 
an ATP binding motif.   
 To visualize the structure of these types of motifs, I performed a PHYRE search 
against TraI to obtain structures that are predicted to be similar to this central portion of 
TraI48,129.  Protein FFH from T. aquaticus is the closest structural homologue predicted for 
TraI.  Figure 7.1 shows the Walker A motif of FFH, which does have the canonical residues 
GxxxxGKT.  This structure shows a metal bound in the active site and also shows a GDP 
molecule.  In this Walker A motif, as in others, the G residues are for loop flexibility, K is to 
orient the γ-phosphate, and T is to help orient the metal ion.  TraI’s putative Walker A box 
does have multiple G residues that could provide flexibility, a positively charged R that could 
replace the K, and a polar negatively charged E that could replace the T.  As seen in Figure 
7.2, FFH has a GTP specific box with a TKxD motif and has a GDP molecule bound to this 
site. The K and D residues are important for making hydrogen bonds to the ribose and the 
guanine.  TraI has both K and D residues in the nucleotide-specific region for binding the 
guanine base.  Table 7.1 shows that there are two potential Walker B boxes present in TraI.  
We hypothesized that TraI does contain a GTPase region in the 309-590 region and planned 
assays and mutagenesis to address this hypothesis. 
7.1.2 Assay development for TraI GTPase 
 Originally TraI’s GTPase activity was investigated using a coupled assay that 
monitored the production of the fluorescent compound resorufin (Figure 7.3).  This assay 
was adopted from an experiment that was used to measure the helicase activity of the Rec 
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family130.   The assay involves several enzymes, including pyruvate kinase, pyruvate oxidase 
and horseradish peroxidase.  The NDP generated from the GTPase is utilized by pyruvate 
kinase to convert PEP to pyruvate.  In the presence of oxygen, pyruvate oxidase converts 
pyruvate to acetylphosphate while generating H2O2.  Then, horseradish peroxidase utilizes 
the peroxide to convert amplex red into resorufin.  However, resorufin is very insoluble in 
water, and thus I was not able to get a reliable standard curve.  To avoid the complications 
with resorufin, I found an alternative assay for probing GTPase activity. 
 The next generation of the assay, adapted from Gosselin et al. utilized one less 
coupled enzyme and monitored the oxidation of  NADH to NAD+  rather than the production 
of resorufin131.  The first step is the same: NDP conversion to NTP by pryuvate kinase, which 
drives PEP conversion to pyruvate.  Then, lactate dehydrogenase converts pyruvate to lactate 
in the presence of NADH; NADH is converted to NAD+.  Figure 7.4 shows the schematic of 
this assay.  The readout of this assay was initially monitored by NADH fluorescence 
emission at 460 nm.  However, the dynamic range of the fluorescent readout was very 
limiting, so NADH absorbance at 350 nm was utilized as the indication of GTPase activity.  
 Figure 7.5 shows the standard curve relating absorbance with concentration of 
NADH. The decrease in absorbance caused by NADH conversion to NAD+ is directly 
proportional to the amount of NTP converted to NDP.  Several control experiments were 
performed to make sure that the coupled enzymes (LDH and PK) were not limiting factors in 
the experiment.  An excess of these enzymes was always utilized.  Also, control reactions 
were performed to make sure that a change in absorbance would only be seen when all 
components of the reaction were present.  As seen in Figure 7.6, control reactions were 
monitored where individual components were separately removed from the reaction.  Each of 
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these control reactions did not have significant change in absorbance signal over time.  The 
full length wild-type is shown on this graph as a positive control reaction.  Also, the reaction 
with no NADH had very low absorbance at 350 nm, indicating that no other assay 
components absorbed at this wavelength. 
7.1.3 Mutation design and protein expression 
 As described previously, the TraI GTPase Walker boxes are not typical, so we were 
interested in identifying the specific residues that are important for activity.  An extensive 
number of constructs were cloned and expressed through mine and Sung Kim’s efforts.  
Table 7.2 shows all of the constructs and mutations that were designed for investigating this 
putative GTPase.  Construct 309-590 represents only the GTPase, 309-958 includes the 
GTPase and a region of unknown function, 309-1504 includes the canonical helicase and 1-
1756 is the full length protein (see Figure 6.3).  Each mutation was made using site-directed 
mutagenesis in the LIC-His plasmid and protein was expressed in BL21 cells.  Proteins were 
purified using nickel affinity and size exclusion chromatography.  Purification buffers are 
similar to those described in the methods section in chapter 2.  Protein was concentrated to 
80 µM and flash frozen in liquid nitrogen. 
7.1.4 Initial results and redirection of project  
 The assay was performed in a 96 well block and read in the PheraStar (BMG).   Each 
well contained a master mix of 0.7 mM PEP, 0.6 mM NADH, 0.1% BSA, 10 mM MgAc, 25 
mM Tris Acetate, pH 7.5 and 4 mM NADH and water.  Then, the appropriate amount of 
GTP or ATP was added to have a range of 0.04-40 µM GTP or ATP.  Data collection began 
immediately after the addition of 2 µM protein.  Background absorbance was subtracted and 
then the NADH absorbance was converted into NADH concentration through the standard 
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curve equation (Figure 7.5) and plotted versus time.  The initial linear portion of the line was 
selected as the initial velocity for the reaction and could then be plotted versus substrate 
concentration to find the Km and Vmax for each protein.   
 Figure 7.7 illustrates the first experimental evidence for the existence of the TraI 
GTPase.  This data indicates that residues G445, G449, Q450 and R451 are important for 
maintaining wild-type level activity.  Further work done by undergraduate Sung Kim has 
shown that although there is a basal level of GTPase activity in the 309-590 region, but the 
canonical helicase from residues 900-1500 is the main ATPase and does not require the 
GTPase portion for full activity.  Thus, the extensive mutational studies of the GTPase are no 
longer a priority.  In retrospect, I have learned that developing a sound biochemical assay and 
fully characterizing the wild-type constructs should be done before any mutational analysis. 
 While Sung and I worked on this part of TraI, Dr. Mike Miley was working on the 
helicase portion of the proteins.  As this work became more intertwined through DNA 
binding assays and activity assays, Mike continued this project while I solved the TraI C-
terminal structure and finished the Symplekin HEAT domain project.  Thus, this GTPase 
characterization has been combined with other lab member’s efforts. Currently, Yuan Cheng 
is working towards solving the crystal structure of the full length TraI protein and also 
finding the ideal piece of DNA for crystallization. 
 
7.2 Progress towards structural characterization of human Eppin 
 For a few months while I was exploring project options, I worked on a project 
pertaining to male contraception, a field that I find especially interesting.  Dr. Michael 
O’Rand, of the Cell and Developmental Biology Department at UNC-CH, is currently 
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leading a team of researchers to investigate structure and function of human spermatozoa 
proteins.    The goal of the collaborative work was to produce recombinant Eppin protein in 
sufficient quantity and purity for crystallization and then to solve the structure of the full 
length or a segment of the Eppin protein.  I worked in collaboration with their laboratory for 
a short time before committing to the Symplekin and TraI projects.   
7.2.1 Introduction  
 Immunization of male monkeys by production of Eppin antibodies was en effective, 
reversible method of contraception: seven out of nine male monkeys developed high anti-
Eppin titer and became infertile, upon ceasing immunization, five of the seven became 
fertilet132.   This was the main result that made Eppin an interesting structural target.  Eppin 
(epididymal protease inhibitor) coats the human ejaculate spermatozoa and has been shown 
to bind to semenogelin (Sg), which is the main protein constituent of seminal fluid.  Binding 
of Eppin to Sg protects the fluid from microbes and also from degradation by proteases133,134.  
These findings make the structural and functional study of Eppin and Sg imperative to 
understand the molecular level mechanism of the male contraception.   
7.2.2 Cloning, expression and purification of human Eppin 
 The DNA for Eppin and semenogelin was received from the O’Rand laboratory.   The 
genes were then cloned into the LIC-MBP plasmid for further characterization. Table 7.3 
lists the primers used in cloning the full length and structural domains of these proteins. The 
134 residue Eppin protein is predicted to contain an N-terminal (residues 1-72) WAP domain 
similar to the elastase inhibitor, elafin (PDB 2REL) and a C-terminal (73-128) domain 
homologous to Kunitz-type tryspin inhibitor (PDB 1KTHa)133.  Both of these domains are 
held in place by multiple cysteine bonds, as can be seen in Figure 7.8.  The full length and 
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WAP domains were over-expressed in E. coli BL21 Origami cells to produce soluble 
proteins.  Typically, E. coli cytoplasm is a reducing environment, so Origami cells were 
chosen because they have mutations in both thioredoxin reductase (trxB) and glutathione 
reductase (gor) genes to enhance disulfide bond formation in the cytoplasm.  The proteins 
were purified using a Ni-affinity column, followed by TEV cleavage to remove the MBP tag, 
and then run again on the Ni-affinity column to purify away the His-MBP tag.  The 
expression was verified with a western blot using Eppin antibodies; Figure 7.9 shows the 
protein after TEV cleavage with amido black staining and western blotting.  The primary 
antibody for the western blot was rabbit anti-eppin, and the secondary antibody is goat anti-
rabbit.  The near full length construct (18-133) in lanes 1 and 2 show the presences of bands 
at molecular weights 14, 28 and 56 kD, which likely corresponds to monomer, dimer and 
tetramer species.  The Kunitz domain (75-133) in lane 3 was not present in either gel.  The 
WAP domain (18-76) was present in bands at 7, 14 and 49 kD, representing possible 
monomer, dimer and heptamer species.   
 The complicating factor for moving forward with crystallization was the presence of 
these multiple oligomerization states for the full length protein and WAP domains.  As seen 
in Figure 7.8, both domains are proposed to be held together by multiple disulfide bonds in 
the structures.  The expression of the human protein in bacterial cells does not guarantee the 
correct formation of these disulfide bonds.  Especially since both domains contain multiple 
cysteine residues, it is difficult to determine if the correct bonds are being formed within each 
domain.  Experiments with reducing agents BME and DTT were able to reduce high 
molecular weight oligomers of Eppin 18-133 to dimer and monomer species, but the proteins 
were still a mixture of two dimer species and one monomer species as seen on an SDS-gel 
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(Figure 7.10).   Also, chemical reduction may disrupt the necessary cysteine bonds present in 
both Kunitz and WAP domains.  To avoid the oligomerization problem, the next course of 
action for this project was to develop a native purification for Eppin out of human ejaculate 
or to produce the protein in insect cells.  However, at this time, the collaboration on the 
Symplekin project was gaining traction, so I was unable to complete the Eppin project.  
Hopefully another graduate student can continue this work.  
 
7.3 Figures and Tables 
Figures and tables are listed in the same order as they appear in the text of chapter 7. 
Table 7.1 Canonical residues for NTPases and TraI residues indicating the presence of a 
GTPase 
 
Figure 7.1 Walker A box of FFH (PDB 1ng1) 
Figure 7.2 Nucleotide-specific box of FFH (PDB 1ng1) 
Figure 7.3 First generation NTPase assay utilizing resorufin 
Figure 7.4 NTPase assay utilizing NADH absorbance 
 
Table 7.2 List of constructs and mutations to investigate the TraI GTPase 
Figure 7.5 Standard curve of NADH 
Figure 7.6 Control reactions with central components omitted separately from the reaction 
Figure 7.7 Initial GTPase activity of select mutants in the 309-1504 TraI construct 
Figure 7.8 WAP and Kunitz domains of homologues proteins to Eppin  
Table 7.3 Primers for Eppin and Semenogelin for LIC cloning  
Figure 7.9 Expression of recombinant human Eppin in BL21 Origami cells 
Figure 7.10 Eppin oligomerization is disrupted by reducing agents 
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Table 7.1 Canonical residues for NTPases and TraI residues indicating the presence of 
a GTPase 
 
Motif Canonical TraI TraI Residues
Walker A box GxxxxGKT GqGGaaGQRE 443‐451
Walker B box hhhhDxxG TVIVDqG or VLITDsG 504‐510 or 532‐538
GTP specific box TKxD MKqD 476‐479
ATP specific box [N/T]SxQ none n/a  
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Figure 7.1 Walker A box of FFH (PDB 1ng1) 
FFH is a GTPase from Thermus aquaticus.  Here is a view of the Walker A box that is 
coordinating the GDP molecule.  The γ-phosphate would be positioned by coordination with 
the threonine and lysine residues.  A calcium metal is also coordinated in this region.  FFH 
has the canonical walker A motif: GxxxxGKT.  
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Figure 7.2 Nucleotide-specific box of FFH (PDB 1ng1) 
Aspartic acid forms two hydrogen bonds with the NH2 of guanine.  The oxygen of guanine 
forms a hydrogen bond with the nitrogen backbone atom of the conserved lysine residue.  
The conserved lysine side chain nitrogen forms a hydrogen bond with the ribose sugar. 
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Figure 7.3 First generation NTPase assay utilizing resorufin  
An NTPase will convert ATP to ADP and Pi.  Then, the coupled reaction with pyruvate 
kinase, pyruvate oxidase and horseradish peroxidase will convert PEP through several 
intermediates including resorufin, which emits 595 nm light.  
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Figure 7.4 NTPase assay utilizing NADH absorbance 
 
 NTPase catalyzes the production of NDP from NTP.  Pyruvate kinase converts NDP to NTP 
while converting PEP to pyruvate.  Pyruvate is then converted to lactate in the presence of 
NADH.  NADH is converted to NAD+ during this final reaction.  Monitoring the loss of 
absorbance at 350 nm indicates the NTPase activity of TraI. 
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Table 7.2 List of constructs and mutations to investigate the TraI GTPase 
Construct Mutation Cloned Grown Purified Done?
309‐590 G443A x x x x
309‐590 G445A x x x x
309‐590 G446A
309‐590 G449A
309‐590 Q450A x x x x
309‐590 R451A x x x x
309‐590 M476A
309‐590 K477A x x x x
309‐590 D479A x x x x
309‐590 WT x x
309‐958 G443A x x
309‐958 G445A x x
309‐958 G446A
309‐958 G449A x x
309‐958 Q450A x x
309‐958 R451A
309‐958 M476A x x x x
309‐958 K477A x x x x
309‐958 D479A x x
309‐958 WT x x
309‐1504 G443A x x x x
309‐1504 G445A x x x x
309‐1504 G446A x x x x
309‐1504 G449A x x x x
309‐1504 Q450A x x x x
309‐1504 R451A x x x x
309‐1504 M476A x x x x
309‐1504 K477A
309‐1504 D479A x x
309‐1504 WT x x
1‐1756 G443A
1‐1756 G445A
1‐1756 G446A
1‐1756 G449A
1‐1756 Q450A
1‐1756 R451A
1‐1756 M476A
1‐1756 K477A
1‐1756 D479A
1‐1756 WT x x
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Figure 7.5 Standard curve of NADH 
Standard curve of NADH concentration vs. absorbance.  R2 value of 0.999 indicates linearity.  
The equation can be rearranged so that any given absorbance can correlate to NADH 
concentration. 
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Figure 7.6 Control reactions for GTPase assay 
 
Control reactions were performed to make sure that there was no change in absorbance signal 
in the absence of each required component.  As expected, the reaction with no NADH has a 
very low absorbance.  There is no significant change in absorbance value for reactions 
without PEP, TraI, PK/LDH or NTP.  Full length TraI was added as a positive control to see 
the significant difference between the negative control reactions and the most active form of 
the wild-type enzyme. 
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Figure 7.7 Initial GTPase activity of select mutants in the 309-1504 TraI construct 
Vmax (% of wild-type) of w TraI 309-1504 mutant constructs.  This construct includes the 
putative GTPase and the canonical helicase regions.  Assay conditions are 2 uM TraI protein, 
0.03-4 M GTP substrate, 1mM Tris-acetate pH 7.5, and no DNA.  The 309-1504 Wild Type 
Vmax = 9.18 nM/s, Km = 0.03 mM. 
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Figure 7.8 WAP and Kunitz domains of homologues proteins to Eppin  
(A) WAP domain from elafin (PDB 2REL).  The four cysteine bonds (yellow) are shown in 
stick representation. The N-terminal region of Eppin is predicted to be structurally similar to 
this WAP domain. (B) Kunitz domain of Kunitz-type domain C5 of collagen alpha 3 (VI 
chain.  Three disulfide bonds (yellow) are shown in stick representation.  The C-terminal 
region of Eppin is predicted to be structurally similar to this Kunitz domain. 
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Table 7.3 Primers for Eppin and Semenogelin for LIC cloning 
Protein  Residue F/R Name 5'‐3' sequence
Eppin 18 F Ep18FLC TAC TTC CAA TCC AAT GCG AAT GTC CAG GGA CCT GGT CTG
Eppin 75 F Ep75FLC TAC TTC CAA TCC AAT GCG GAT GTA TGC GAA ATG CCA AAA
Eppin 133 R Ep133RLC TTA TCC ACT TCC AAT GCG CTA GGG AAA GCG TTT ATT CTT GCA
Eppin 76 R Ep76RLC TTA TCC ACT TCC AAT GCG CTA TAC ATC TTG TTT GAG ATC TAA
Sg 26 F Sg26FLC TAC TTC CAA TCC AAT GCG GGT GGA TCA AAA GGC CGA TTA
Sg 164 F Sg164FLC TAC TTC CAA TCC AAT GCG AGG CTG TGG GTT CAT GGA CTA
Sg 282 F Sg282FLC TAC TTC CAA TCC AAT GCG AAG GCA AAT AAA ATA TCA TAC
Sg 265 R Sg265RLC TTA TCC ACT TCC AAT CGG CTA TGT AAA TAA TGG GTT TCG GTC
Sg 283 R Sg283RLC TTA TCC ACT TCC AAT CGG CTA TGC CTT TCG GCC ATG CTG TTG
Sg 401 R Sg401RLC TTA TCC ACT TCC AAT CGG CTA TTC ACC ATG CCA TGG CTC TTG  
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Figure 7.9 Expression of recombinant human Eppin in BL21 Origami cells 
Amido black staining and western blot of human Eppin produced in BL21 Origami cells.  
Lane 1: Eppin 18-133 (14 kD monomer) post TEV cleavage flow through. 
Lane 2: Eppin 18-133 (14 kD monomer) post TEV cleavage elution. 
Lane 3: Eppin 75-133 (7 kD monomer) post TEV cleavage flow through. 
Lane 4: Eppin 18-76 (7 kD monomer) post TEV cleavage reaction (not purified). 
Lane 5: Eppin 18-76 (7 kD monomer) post TEV cleavage flow through. 
Lane 6: Eppin 18-76 (7 kD monomer) post TEV cleavage elution. 
Western blot analysis shows lanes 1 and 2 contain bands at 56 kD (tetramer) 28 kD (dimer) 
and 14 kD (monomer).  Lanes 4, 5, and 6 contain bands at 7 kD (monomer) and a series of 
bands between 7-14 kD, perhaps representing dimerization.  Lanes 4 and 6 also have bands at 
49 kD, which could represent a heptamer. 
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Figure 7.10 Eppin oligomerization is disrupted by reducing agents 
 
Eppin 18-133 was subject to conditions to attempt to disrupt oligomerization.  Eppin was 
resistant to Triton and Urea.  DTT (1 or 10 mM) and 10 mM BME disrupted high molecular 
weight oligomerization and produced monomer sized protein.   The two dimers were not 
reduced by either DTT or BME. 
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